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Introduction

Groundwater is a primary source of drinking
water for about 50 percent of the population in the
U.S. This source of drinking water has been generally regarded as safe from contamination. Several
papers indicate that nwnerous underground storage
tanks containing petroleum products may be leaking and contaminating public water supply wells
across the U.S.(Matis, 1971; Ferguson, 1979;
Woodhull, 1981; Bunnaster and Harris, 1982;
Lehman, 1984; Dowd, 1984; OTA, 1984). A
study conducted by the Utah Bureau of Solid and
Hazardous Wastes in 1985 concluded that there are
at least 2,314 underground steel tanks, most of
which are used to store gasoline and diesel fuel, in
Utah which are more than 20 years old and may be
leaking.
Contamination of well water by petroleum
products from Jeakingunderground storage tanks
(LUST) is a matter of increasing concern. LUST
pose a serious threat to the groundwater and public
health. Leaks of petroleum products from LUST
at industrial plants, commercial establishments
(e.g., automobile service stations), and other operations could be expected to increase the types and
concentrations of petroleum products in groundwater used for drinking and exposure of hwnans to
the toxic effects of these chemical compounds.

Petroleum products are persistent and highly
mobile contaminants which are difficult to remove
from groundwater. In addition, many of these
chemicals are known or suspected carcinogens or
mutagens which can pose undesirable human
health risks (e.g., cancer, birth defects, and other
chronic conditions) at 10 ppb and below (Council
on Environmental Quality, 1980). There is a need
for more research on the types and concentrations
of petroleum products (e.g., benzene, toluene,
ethylbenzene) found in public water supply wells
used for drinking water and the immunotoxic and
neurotoxic effects of these organic compounds.

The objectives of this research project were:
1. To characterize petrolewn products in raw
water from wells used for drinking water
in selected areas (industrial, commercial,
and other) of Utah.
2. To evaluate the toxicity of selected petroleum products in experimental animals,
with emphasis on the following:
a.

Immunotoxic and hypersensitivity
effects.

b. Neurotoxic and behavioral effects.
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Methodology

Characterization of Petroleum
Contaminants in Well Water
Numerous well water sampling trips were
conducted during the 1985-87 research project
period. A total of 5 shallow USGS monitoring
wells (depth to sediment: 12 to 14 feet) and 6 deep
drinking water wells (140 to 380 feet deep) located
over an area extending from Woods Cross, Utah, to
Orem, Utah, were sampled for petroleum contaminants. All wells were located in the vicinity of
petroleum refineries, gasoline stations, or other
activities (e.g., steel manufacturing, explosives
production, public works).
After purging each well by evacuating a
minimum of three well casing volumes, water
samples for volatile and semi volatile organic pollutant analyses were collected in duplicate or triplicate with a clean Teflon bailer or by hand, put
into appropriate amber glass bottles with teflon
septa and screw caps, and packed in ice coolers for
transportation to the Utah Water Research Laboratory. At the laboratory, all samples were stored at
4°C for later chemical analyses. Temperature, pH,
and conductance of water samples collected in the
field were measured and recorded. Temperature was
measured with a YSI Model 33 S-C-T Meter,
Orion SA 250 meter or a dry bulb thennometer. A
Leeds and Northrup Model 7417 Meter or Orion
SA 250 Meter were used to measure pH. Conductance was measured with a YSI Model 33 S-C-T
Meter.
All sampling equipment that would be in
contact with well water was cleaned with Micro
laboratory cleaning solution, washed thoroughly
with tap or distilled water, rinsed several times
with acetone, and then washed with distilled water
before use. For each well where a bailer was used·
to coHect water, samples for volatile organic pollutants were obtained from the first bai1er of well
water. Water samples for semi volatile organic
pollutants were obtained from subsequent bailer
well water samples which had been thoroughly
mixed in a large stainless steel bucket. For each
well where water samples were collected by hand,
the well water was allowed to flow for about 30
minutes before collection of water samples.
Water samples were analyzed for traces
of volatile organic petroleum pollutants by EPA
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Purge and Trap Analysis Method 5030. Following
extraction of the semivolatile organics in the water
samples by solvent extraction (EPA Separatory
Funnel Liquid-liquid Extraction Method 3510), the
extractables (acids and base neutrals) were analyzed
by EPA GC/MS Method 8250 for semivolatile
organics--Packed Column Technique.
A concentrated effort was made to locate and
sample shallow drinking water wells (wells capable
of drawing surface water into them) in areas where
Leaking Underground Storage Tanks (LUST) were
known or suspected. This task was a diffi uIt one.
After consulting with water personnel at various
agencies (e.g. North Davis, South Salt Lake City,
and Provo County Health Departments, USGS
Office in Salt Lake City, Bureau of Public Water
Supplies in the State of Utah Department of
Health, and Orem City's Engineering Office), it
was apparent there are few, if any, shallow wells in
the present study area that are used for drinking
purposes. According to a Bureau of Public Water
Supplies (Salt Lake City) engineer, there may be a
few private shallow wells in the area we are
studying that have not yet been inventoried and
which are most likely used for agricultural irrigation or live-stock watering purposes. There is a
possibility some of these wells may be serving as
a source of drinking water.
Because of the above findings, we decided to
collect water samples from shallow USGS monitoring wells and deep drinking water wells (wells
that penetrate an impermeable strata and prevent
surface water from being pumped or injected into
them) in the study area where LUST were known
or suspected. In future studies, more emphasis
should be placed on obtaining water samples from
shallow monitoring wells and nearby deep drinking
water wells in those parts of a study area where
LUST are known or suspected and then examining
these samples for types and concentrations of
petroleum contaminants.

Toxic Effects of Selected Petroleum
Contaminants in Laboratory Animals
Toxicity studies were conducted from August
25, 1985, through June 30, 1987. For the 198586 project period, studies were perfonned to determine the immunotoxic and neurotoxic effects of
selected petroleum contaminants, namely, benzene,
toluene, and phenol in laboratory animals (mice)

following continuous ingestion of drinking water
containing various concentrations of tbe test
cbemicals.
For the 1986-87 project period. studies were
conducted primarily to detennine the immunotoxic
and neurotoxic effects resulting from tbe interaction of two petroleum contaminants. namely,
benzene and toluene, in laboratory animals (mice)
following continuous ingestion of drinking water
containing combination concentrations of the two
test chemicals.
Benzene-induced immunotoxicity and
neurotoxicity in mice
Experiments were conducted to detennine the
effects of benzene on the immune and nervous systems of mice. Analytical reagent grade benzene
(99.9% purity, IT Baker Cbemical Co., Phillipsburg, Nl), was dissolved in nonnal tap water to
provide nominal concentrations of 40, 200, and
1,000 mg/L. Benzene has a solubility of 1,780
mg/L in water at 25°C (USBPA. 1980). The
benzene-treated water was administered to male,
adult CD-I mice (approximately 20-22 gm initial
weight) continuously for 28 days via drinking
water; the control group received untreated tap
water. In addition to tbe benzene-treated tap water
given as drinking water. all animals received lab
chow. To minimize decomposition and to maintain the concentration of benzene. drinking water
was provided in glass water botties. shaken frequently during treatment and was changed every 3
days. Feed and water consumption was monitored
continuollsly, and animals were weighed once eacb
week. Benzene concentration in drinking water
was confinned on different days by gas chromatography (USEPA, 1982). The observed concentrations for benzene were 31, 166, and 790 mg/L.
Five mice per test group were housed in plastic cages on bardwood-chip bedding and maintained
on a 12 hour light-dark cycle at an ambient room
temperature of 21 ± 1°C during tbe experimental
period. All animals in the study were individually
identified with color bands on their tails.
To assess the general toxic effects of benzene
in mice following continuous ingestion of drinking water containing various concentrations of
benzene, food. water consumption, and individual
body weight gain were monitored throughout the
experimental period. Relative organ (kidney.
spleen, liver, and thymus) weights of each animal
were recorded at the time of animal sacrifice. In
addition to the above observations, tbe following
immunotoxic evaluations were perfonned on the
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test animals after 4 weeks of treatment to evaluate
benzene-induced immtmotoxicity: I) Hematological tests [e.g. red blood cell (RBC) and white blood
cell (WBC) counts] to detennine benzene hematoxicity; 2) Mitogenesis Assay for inducing and
measuring animal splenic lymphocyte proliferation
in response to mitogens and antigens in vitro; 3)
Mixed Lymphocyte Response (MLR) in whicb the
mixing of two populations of allogeneic lymphoid
cells (stimulator and responder ceUs) results in T
cell proliferation; 4) Cell-mediated Cytolytic Response to evaluate splenic lymphocytes of test animals for cytotoxic cells; 5) Plaque Fonning Assay
(Cunningham and Szenberg, 1956) to evaluate the
primary antibody response by mouse splenic lymphocytes toward sheep red blood cells (SRBC), a
T -dependent antigen; and, 6) Enzyme Linked
Immunosorbent Assay (ELISA) to detennine
specific hemolysin.
After 4 weeks of benzene treatment and for
neurotoxic evaluations, five additional mice from
the control and eacb of tbe test groups were killed
by decapitation and their brains quickly dissected
into six anatomic regions (hypothalamus, medulla
oblongata, cerebellum, midbrain, corpus striatum,
and cortex [Glowinsky and Iversen, 1966]). The
midbrain included tbe hippocampus, thalamus, and
subthalamus regions. Brain tissues were immediately placed into tared vials containing several
volumes, in relation to tissue weight, of ice-cold
0.05 M HCI04 with 0.5% cysteine and then frozen
at -80°C until analyzed. To minimize possible
diurnal variations in regional brain neurotransmitter concentrations, all animals were sampled
between 10:00 and 12:00 am. on the same day.
Samples from various brain regions were
homogenized and centrifuged at 10,000 g for 60
minutes, and tbe supernatant fractions were passed
through a 0.2 !.lm pore filter by gentle centrifugation for 3 minutes at 1000 g. These filtrates
were analyzed for major catecholamines and indoleamines, namely dopamine (DA), norepinephrine
(NE), 5-hydroxytryptamine (5-HT, serotonin), and
their principal metabolites, i.e. dihydroxypbenylacetic acid (DOPAC), homovaniUic acid (HVA). 3methoxy-4-hydtoxy-mandelic acid (VMA), and 5hydroxyindoleacetic acid (5-HIAA) using high
pressure liquid chromatography with a multiple
electrode electrochemical detector (Mayer and
Shoup, 1983) to detennine possible changes in tbe
levels of these selected neurotransmitters that
control behavior.
The neurocbemicals selected for evaluation
are known to play an important role in physiology
and behavior (poirier and Bedard, 1984; Rogawski
and Baker, 1985). Changes in concentrations of

their metabolites provide an appropriate indication
of neura] activity (Commissiong, 1985). Assays in
various brain regions are essential to detect
perturbations of a specific neurotransmitter(s).
The data were analyzed by one-way analysis
of variance followed by the least significant difference test, if F ratios were significant. A P<0.05
was accepted as statistically significant.
Toluene-induced immunotoxicit.v
and neurotoxicit.v in mice
Experiments were also conducted to determine
the effects of toluene on the immune and nervous
systems of mice. Chromatography grade toluene
(99.7% purity, Burdick and Jackson Labs, Inc.,
Mu."lkegon, MI) was dissolved.in normal tap water
to provide nominal concentrations of 20, 100, and
500 mg/L. Toluene bas a solubility of 535 mgIL
in water at 25°C (USEPA, 1980b). The toluenetreated water was also administered to the CD-I
mice continuously for 28 days via drinking water;
the control group received untreated tap water.
These animals also received lab chow. To minimize decomposition and to maintain the concentration of toluene, drinking water was provided in
glass water bottles, shaken frequently during treatment and was changed every 3 days. Feedand
water consumption was monitored continuously,
and animals were weighed once each week.
Toluene concentration in drinking water was also
confirmed on different days by gas chromatography
(US EPA, 1982). The observed concentrations for
toluene were 17, 80, and 405 mg/L.

As with the benzene study, five miCe per test
group were housed in plastic cages on hardwood
chip bedding and maintained on a 12 bour Iightdark cycle at ambient room temperature during the
experimental period. All animals received lab
chow and were individually identified with color
bands on their tails.
To assess the general toxic effects of toluene
in mice following continuous ingestion of drink- .
ing water containing various concentrations of
toluene, food and water consumption, and individual body weight gain were also monitored
throughout the experimental period. The methods
for evaluating toluene-induced immunotoxicity and
neurotoxicity in mice were the same as those used
for benzene.
Phenol-induced immunotoxici!y and
neurotoxicity in mice
Experiments were also conducted to determine
the effects of phenol on the immune and nervous
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systems of mice. Analytical reagent grade phenol
was dissolved in normal tap water to make the
nominal concentrations of 5, 20, and 100 mgIL.
Phenol has a solubility of approximately 67 gIL
(Windholz, 1976). The phenol-treated water was
administered to the CD-I mice continuously for 28
days via drinking water; the control group received
untreated tap water. In addition to the phenoltreated tap water given as drinking water, all animals received lab chow.
To minimize decomposition and maintain the
concentration of phenol, drinking water was provided in glass water bottles, shaken frequently
during treatment and changed every 3 days. Feed
and water consumption was monitored continuously, and animals were weighed once each week.
Phenol concentration in drinking water was
confirmed on different days by the direct
photometric method (APHA, 1980). Observed
concentrations for phenol were approximately 95
percent of the nominal concentrations (4.75, 19,
and 95 mg/L) used.
Similar to the benzene and toluene studies,
five mice per test group were housed in plastic
cages on hardwood chip bedding and maintained on
a 12 hour light-dark cycle at ambient room
temperatnre during the experimental period. All
animals also received lab chow and were
individually fitted with color bands on their tails.
The methods for assessing the general toxic
effects of phenol in mice following continuous
ingestion of drinking water containing various
concentrations of phenol and for evaluating
phenol-induced immunotoxicity and neurotoxicity
in mice were the same as those used for the
benzene and toluene studies.
Effect of benzene. and toluene. alone or combined on immunotoxicity and neurotoxicity in
mice.
Experiments have been conducted to determine the effects of combinations of benzene and
toluene on the immune and central nervous
systems of mice. Male, adult, CD-l mice were
separ-ated into four groups (five mice pet group):
1) control group exposed to untreated tap water; 2)
benzene group exposed to benzene-treated tap
water; 3) toluene group exposed to toluene-treated
water ;and, 4) mixture group exposed to a mixture
of benzene and toluene in tap water. Two
experiments were performed.
In the first experiment, the animals were
exposed to 200 mg/L benzene, 400 mg/L toluene,
and 200 mg/L benzene + 400 mg/L toluene. In

the second experiment, the animals were exposed
to 200 mg/L benzene, 100 mg/L toluene, and 200
mg/L benzene + 100 mg/L toluene. The animals
were continuously fed tap water ad. lib., containing
the various concentrations of benzene, toluene, and
benzene + toluene for 4 weeks. The animals were
housed, maintained, and identified with color bands
on their tails as in the other toxicity studies.

6

To assess the general toxic effects in mice,
food and water consumption were monitored continuously, and animals were weighed once a week.
The methods for evaluating the effects of combinations of benzene and toluene on the immune and
central nervous systems of mice were the same as
those used for the benzene, toluene, and phenol
toxicity studies.

Principal Findings and Significance

This portion of the final research project
report has been chronologically divided into the
following parts: 1) characterization of petroleum
contaminants in well water; 2) benzene~induced
immunotoxicity and neurotoxicity in mice; 3)
to1uene~induced immunotoxicity and neurotoxicity
in mice; 4) phenol-induced immunotoxicity and
neurotoxicity in mice; 5) immunotoxic effects of
benzene (200 mg/L), toluene (400 mg/L), and a
mixture of benzene (200 mg/L) + toluene (400
mg/L) in mice; 6) immunotoxic effects of benzene
(200 mg/L), toluene (100 mg/L), and a mixture of
benzene (200 mg/L) + toluene (100 mg/L) in
mice; 7) neurotoxic effects of benzene (200 mg/L),
toluene (400 mg/L), and a mixture of benzene (200
mgIL) + toluene (400 mg/L) in mice; and 8)
neurotoxic effects of benzene (200 mg/L), toluene
(100 mg/L), and a mixture of benzene (200 mg/L)
+ toluene (100 mg!L) in mice. In the interest of
clarity and conciseness, the data are summarized
and presented in tabular form (see Appendix A for
tables) and results are discussed as they are
presented
Characterization of Petroleum
Contaminants in Well Water
Table I shows the temperature, pH, and/or
conductance values of well water samples collected
from five USGS shallow monitoring wells during
the 1985-1987 research project period. Water temperatures ranged from 6.8 to 18.0°C. The pH of
the water samples ranged from 5.5 to 7.8. Conductance values O.unhos/cm) ranged from 1,339 to
5,105. Temperature and pH values of well water
samples collected from six deep drinking water
wells during the project period are presented in
Table 2. Water temperatures for these samples
ranged from 12.8 to 19.4°C. The pH of the water
samples ranged from 6.2 to 7.4.
Results of volatile or semivolatile organic
pollutant analyses of various shallow monitoring
well water samples collected during the 1985-87
project period are presented in Table 3. Volatile
organic compounds detected in the shallow well
water samples by Purge and Trap Analysis (Table
3) were: benzene (0.81-196.83 I1g/l), toluene
(0.09-122.33 I1g/l), ethyl benzene (0.96~101.27
I1g/J), p-xylene (0.25-26.98 I1g/l), m-xylene
(0.29-8.36 I1g/l), o-xylene (0.31-3.08 I1g/l), 1,3,5-
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trimethylbenzene (5.36-62.45 I1g/l), 1,2,3;4-tetramethylbenzene (5.83-9.49 I1g/l), 1,2,4,5-tetramethylbenzene (1.27-10.46I1g/l), and naphthalene
(4.14-6.71 I1g/l). Volatile or semivolatUe organic
compounds detected in the shallow well water samples by Methylene Chloride Extraction (Table 3)
were: Benzene (1.83-36.21 I1g/l), toluene (1.1317.39 I1g/l), ethylbenzene (17.89-53.23 I1g/l), pxylene (0.48 I1g/l), 1,2,3,4,.tetra-methylbenzene
(9.57 I1g/l), 1,3,5-trimethylbenzene (15.22-21.06
I1g/l), and I-methylnaphthalene (4.96 I1g/l).
Benzene (0.81-196.83 Ilg/J), toluene (0.09122.33I1g/l), ethylbenzene (0.96-101.29I1g/l), and
o-xylene (0.31-3.08 I1g/l) were detected in well
water samples from three shallow monitoring
wells (Well numbers 3, 4, and 5) which were
located near gasoline pumps. A level up to 6.4
mg/L toluene has been detected in drinking water
(Tardiff and Youngren, 1986). Benzene, toluene,
ethylbenzene and o-xylene are known chemical
constituents of gasoline.
Well number 3 was located at the Sandy
Public Works Department (8775 South 700 West,
Sandy, Utah). Three gasoline pumps were located
. 90 to 100 feet east of the monitoring well. Well
number 4 was located in a parking lot approximately 105 feet north of a Sinclair gas station at
7000 South 2000 East, Salt Lake City, Utah.
Well number 5 was located in an apartnient complex at 450 South, 945 East, Salt Lake City,
Utah. A Ge/MS analysi., of water samples from
well number 3 indicated the presence of numerous
other organic compounds as shown in Table 4.
The following organic compounds were also detected in water from well number 3: p-xylene (0.2526.99 I1g/l), 1,3,5-trimethylbenzene (12.23-62.45
I1g/l), 1,2,3,4- tetramethylbenzene (5.83-9.49
I1g/l), 1,2,4,5-tetramethylbenzene (1.27- 13.96
I1g/l), m-xylene (0.29 I1g/l), and naphthalene
(4.14-5.18 11811). In water from well number, 4
other organic compounds detected were: .p-xylene
(6.50 I1g/l), m-xylene (2.49 I1g/l), 1,3,5-trimethylbenzene (2.68 I1g/l), 1,2,4,5- tetramethylbenzene
(2.66I1g/l), and naphthalene (3.36 I1g/l). In water
from well number 5 other organic compounds
detected were: p-xylene (14.54 I1g/l), m-xylene
(8.36 I1g/l), 1,3,5-trimethylbenzene (6.70 I1g/l),
1,2.4,5-tetramethylbenzene (6.90 I1g/l), and naphthalene (4.81 I1g/l). Surprisingly, although not
detected by Purge and Trap Analysis during the
first sampling trip (9/09/85), toluene (1.13 I1g/1),
1,2,3,4-tetramethylbenzene (9.57 I1g/l), and 1-

metbylnapbtbalene (4.96 Ilg/l) were detected by
Methylene Chloride Extraction in water from well
number 2 during tbe second sampling trip
(02/06/86). The shallow monitoring well from
which this water sample was collected is located
adjacent to a private residence and about one and
one-half blocks southwest of a public gasoline
station. Benzene (17.98 Ilg/l) was detected by
Purge and Trap Analysis in water from well number 2 during a later sampling trip (04/2A/87).
No volatile or semivolatile organic compounds were detected in any of the deep well water
samples collected during the entire research project
.period. Table 5 shows the organic compounds
detected by GC/MS analysis of all shallow monitoring well water samples analyzed during the
study.
Benzene-induced Immunotoxicity and
Neurotoxicity in Mice
Benzene-induced immunotoxicity in mice
Continuous exposure of adult CD-I mice to
various concentrations of benzene (0, 40, 200,
1000 mg/L) via drinking water over a 4 week
period did not cause mortality or induce any clinical toxicity signs in the animals. Overall, there
was no change in total feed and water consumption; bowever, water consumption by mice in the
1000 mg/L treatment group was slightly decreased.
No gross lesions were observed on any of the
organs of mice in all treatment groups at the time
of sacrifice. There was also no significant change
in body weight gain (Table 6).
Table 7 shows the organ and body weigbts of
mice following 4 weeks of benzene exposure.
Spleen and thymus decreased in weight at all the
benzene concentrations. Spleen showed a significant decrease in weight at the 1000 mg/L level.
Kidney increased in weight at all the concentrations and sbowed a significant increase in weight at
the 1000 mg/L level.

The effects of 4 weeks of benzene exposure
on spleen cellularity and selected blood parameters
are presented in Table 8. Total spleen cellularity
decreased significantly at the 1000 mg/L level. It
can be seen from tbe table that WBC and RBC
counts decreased significantly with increased dose.
PCV also decreased significantly at the 200 and
1000 mg/L concentrations. Benzene is a proven
hemotoxin (Fishbein, 1984). In man, it is
causally related to pancytopenia (USEPA, 1980).
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From the differential WBC counts sbown in
Tahle 8, it can be seen that there was a significant
depression of lymphocytes at 40 and 1000 mg/L,
and a significant stimulation of neutropbils at
tbese two concentrations. While all blood cell
types are targets for benzene poisoning, lymphocytes are particularly sensitive (Rosenthal and
Snyder, 1985).
Table 9 shows tbe effects of benzene exposure on the uptake of (=4H]-thymidine by mouse
spleen cells in culture. Spleen cells are evaluated
for their ability to proliferate after mitogen stimulation. Following four weeks of exposure, the
proliferative response of mitogen-treated spleen
cells is biphasic, significantly elevated in low dose
(40 mg/L) group and significantly decreased in
higher dose (200, 1000 mg/L) groups. The results
of the mixed lymphocyte response to allogeneic
cells (Table 10) are the same as the mitogenesis
results (Table 9), and there are also significant
differences.

The killing of target cells by sensitized Tlymphocytes is an important indicator of cellmediated immunity. Tbe effect of benzene
exposure on cell-mediated cytolytic response is
shown in Table II. The results of SlCr-reJease
assay show that cell-mediated cytolytic response
against tumor cells (target cells) is affected by
benzene exposure. The response is also biphasic,
elevated in low dose (40 mg/L) group and decreased
in high dose (200, 1000 mg/L) groups. There is
a significant depression in response at the 200
and 1000 mg/L levels in the 50:1 effector-to-target
cell ratio. The results for the 25:1 ratio also
showed significant stimulation in the 40 mg/L
group, but significant suppression only at the
1000 mg/L level.
After 4 weeks of benzene exposure via
drinking water, animals were injected with sheep
red blood cells (SRBC) and their anti-SRBC
antibodies evaluated by enumeration of plaqueforming cells (PFC). The effect of 4 weeks of
benzene exposure on the antibody plaque-forming
cells (PFC) is presented in Table 12. The results
of primary antibody response show that there is a
significant depression of plaque formation by cells
collected from animals exposed to 200 and 1000
mg/L benzene in drinking water and no significant
stimulation in the 40 mg/L group. The titer of uSRBC antibodies corresponds with the changes in
numbers of PFC. According to the EUSA tests, a
significant inhibition was found at the highest dose
(1000 mg/L) group (Table 12).

Toluene-induced Immunotoxicity and
Neurotoxicity in Mice

BeD7..ene-induced neurotoxicity in mice
The regional concentrations of catechol amines and indoleamines in different brain regions
are presented in Tables 13, 14, 15 and 16.
Ingestion of benzene in drinking water induced
significant increases in catecholamine neurotransmitters in several brain regions at all three
benzene-treated levels when compared with control
animals (Tables 13 and 14).
The significant benzene-induced increases of
concentrations of NE relative to controls were
found in the hypothalamus (200, 1000 mg/L),
medulla oblongata (200 mg/L), cerebellum (1000
mg/L), midbrain (40, 200, and 1000 mg/L) and
cortex (40, 200 and 1000 mg/L). The concentration of VMA, a metabolite of NE, also showed
a significant increase in the cerebellum, corpus
striatum and cortex (40, 200 and 1000 mg/L).
DA, the parent neurotransmitter of dopaminergic
neuronal systems, exhibited a moderate increase in
various brain regions but this finding was not
significant.
Significant increases in the OOPAC
concentration, one metabolite of OA, were found
in the hypothalamus (200 mg/L), and in other
brain regions such as the medulla oblongata (40,
200 mg/L), midbrain (40, 200, and 1000 mg/L),
corpus striatum (1000 mg/L), and cortex (40, 200
mg/L). HVA, the last step metabolite of OA, was
also significantly increased in the midbrain (40,
200, and 1000 mg/L). Likewise, there were
significant increases of HVA in the corpus
striatum (1000 mg/L) and in the cortex (40, 200
mg/L).
No significant increases of HVA
concentrations were found in the other brain
regions (hypothalamus, medulla oblongata, and
cerebellum).
Benzene ingestion also induced significant
increases in indole amine neurotransmitters in
several brain regions (Tables 15 and 16). The
levels of 5-HT were significantly increased in
midbrain (all treatment groups), cortex (40, 200·
mg/L), and medulla oblongata (40 mg/L), the
regions of the brain containing relatively high
amounts of this amine. Concommitant with the
observed increases of 5-HT concentrations, levels
of its metabolite (5-HIAA) were likewise
significantly increased in the same brain regions
and the same dose groups. These [mdings of
alterations in brain neurotransmitter concentrations
may support the reported clinical and behavioral
effects associated with benzene exposure (Haley,
1977; Brief et al., 1980; Evans et al., 1981;
Dempster et al., 1984).
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Toluene induced immuootoxicity in mice
Continuous exposure of CD-l male mice to
various concentrations of toluene (0, 20, 100,500
mg/L) via drinking water over a 4 week period did
not induce mortality or overt signs of toxic stress.
Overall, a dose-related slight decrease of total food
commmption was observed; however, there was no
change in total water consumption. No gross
lesions were found on any of the organs of mice in
all treatments groups at the time of sacrifice.
There was also no change in body weight gain
(Table 17).
Table 18 shows the organ and body weights
of mice following 4 weeks of toluene exposures.
The weight of liver was significantly increased in
the two higher dosed groups (100, 500 mg/L).
Thymus, the primary lymphatic tissue, showed a
significant decrease in weight at the 500 mg/L dose
level. Spleen and kidney showed no change in
weight during the experiment

The effect<; of 4 weeks of toluene exposure on
spleen cellularity and selected blood parameters are
given in Table 19. Total spleen cellularity did not
show significant decrease in any of the treatment
groups. The hematological data demonstrated a
significant decrease in peripheral leukocytes at the
highest dose level (500 mg/L) and a slight increase
in the other two toluene-treated groups (20, 100
mg/L). Hobara et al., (1984), observed significant
leukocyte decreases in mature cross-breed dogs
exposed by inhalation to more than 500 ppm
toluene.
From the differential WBC counts shown in
Table 19, it can be seen that there was no significant depression of lymphocytes with increased dose
and only a slight increase in neutrophils. No
change of monocytes was found in all the treated
groups when compared to the control group. There
is general agreement that toluene does not have the
hematotoxic properties of benzene (Fishbein,
1985, U.S. EPA, 1980b).
Table 20 shows the effects of toluene
exposure on the uptake of [3H]-thymidine by either
mitogen stimulated or nonmitogen stimulated
mouse splenic cells in cultures after 4 weeks of
treatment. A significant decrease in [3H]-thymidine incorporation in non-mitogen stimulated cultures was observed at all dose levels in the in vivo
toluene-treated splenic cells. There also appeared
to be a depressing mitogenesis response to all
mitogens, i.e. LPS, PWM, ConA, and PHA.

Statistical analysis revealed significant
differences from controls at 20, 100, and 500
mg/L toluene dose levels. From these findings,
toluene was shown to have a significant depressing
effect on the mitogenic response to both T cell
mitogens (ConA, PHA) and B cell mitogens (LPS,
PWM).
Table 21 demonstrates the lymphocytetransformation response to allogeneic cells.
Similar to mitogenesis, a significant reduction of .
[3H]-thymidine incorporation occurred in nonstimulated and allogeneic cell cultures in all
toluene-treated mice splenic cells. These results
show that toluene depressed T cell function in
response to allogeneic cells.
The effects of toluene exposure on cellmediated cytolytic response are presented in Table
22. The results of 51Cr-release assay show that
cell-mediated cytolytic response against tumor cells
(target cells) is moderately affected by toluene
exposure. The decreased responses are a doserelated effect. A significant reduction was only
seen at the highe.~t dose levels (500 mg/L) in the
50:1 effector-to-target cell ratio.
After 4 weeks of toluene exposure via drinking water, our studies demonstrated that toluene
causes an immunosuppressive effect by decreasing
the development of SRBC-specific plaque-forming
cells (fPC) (Table 23). This immunosuppression
was a dose-related effect but the significant suppressions were only found in the 500 mgIL
toluene-treated group. The results of ELISA test
showed that the titer of a-SRBC antibodies did not
decrease significantly (Table 23).
Toluene-induced neurotoxicity in mice
The levels of toluene used in this study did
not cause the animals to display noticeable clinical
behavioral effects during the course of the experiment. After 4 weeks of toluene treatment via
drinking water, toluene ingestion induced significant increases in catecholamine neurotransmitters
in several brain regions. The effects were often
maximal at 100 mg/L with no further increase
apparent at the highest dose (Tables 24 and 25).
Toluene exerts its greatest effect on NE. In
the hypothalamus, a region especially rich in this
neurochemical, significant toluene-induced
increases were detected relative to the control
group in all three treatment groups. The three
doses of toluene also caused significant increases
in concentrations of NE in the midbrain, one major
region containing relatively high amounts of
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this amine. Likewise, a significant increase in NE
concentrations was seen in the medulla oblongata
in the 100 mg/L group (Table 24).
The apparent increases of NE in the other
three brain CODlpartments (cerebellum, corpus striatum, and cortex), the regions with lower amounts
of NE, were not significant as determined by
analysis of variance. The concentration~ of VMA,
a major metabolite of NE, were also influenced by
toluene treatment. It can be seen that there were
significant increases of VMA in midbrain and
corpus striatum at the two highest doses (100, 500
mg/L), medulla oblongata at the J 00 mg/L, and
cortex in the 500 mg/L group (Table 25).
Levels of DA and its principal metabolites,
namely, DOPAC and HVA, showed significant
increases in several brain regions following 4
weeks of toluene treatment. For example, in the
corpus striatum, a region with the highest concentrations of these three neurotransmitters, there were
significant increases of DA in the two higher dosed
groups and of HVA in the highest dosed group.
Concentrations of DA were also significantly
increased in the hypothalamus at all three toJuene
doses. DOPAC showed a significant increase in
the medulla oblongata and HVA in the cerebeUum
at the 100 mg/L dose. The medulla oblongata and
the cerebellum are two brain regions containing
relatively low concentrations of DOPAC, DA, and
HVA. DOPAC also showed a significant increase
in the hypothalamus at the 20 and 100 mg/L
doses.
Toluene ingestion also induced significant
increases in indoleamine neurotransmitters, 5-HT
and its major metabolite 5-HIAA (Tables 26 and
27). Remarkable changes were observed in 5-lIT
concentrations. There were significant increases of
5-lIT in all brain regions except the cerebellum
where 5-HT occurs in small amounts. Significant
increases of 5-lIT were found in hypothalamus
(100 mg/L), medulla oblongata (100,500 mg/L).
midbrain (20, 100, and 500 mg/L), corpus striatum
(100, 500 mg/L), and cortex (20. 100, and 500
mg/L). Concommitant with the observed increases
of 5-HT concentrations. concentrations of 5-HIAA
also increased, primarily in the 100 mg/L dose
groups such that significant increases of this
chemical occurred in the hypothalamus, medulla
oblongata, and cortex regions of the brain.
The neurotoxic properties of toluene represent
the main health hazards (Fishbein, 1985). The
study results suggest that toluene has an effect on
adrenergic, dopaminergic. and serotonergic pathways. These observations support the hypothesis
that physio-chemical properties of toluene may
lead to changes in membrane fluidity.

Phenol-induced Immunotoxicity and
Neurotoxicity in Mice
Phenol-induced immunotoxicity in mice
Continuous exposure of adult, CD-l mice to
various concentrations of phenol (0, 5, 20, 100
mg/L) via drinking water for 4 weeks had no effect
on total food and water consumption or on hody
weight gain (Table 28). However, 4 weeks of exposure· did result in non-significantly decreased
spleen, thymus, and liver weights and increased
kidney weight (Table 29). No gross lesions were
observed on any of the organs of mice in all treatment groups at the time of sacrifice.
The effects of 4 weeks of phenol exposure on
spleen cellularity and selected blood parameters are
given in Table 30. Total spleen cellularity did not
sbow a significant decrease in any of the treatment
groups. Phenol exposure resulted in a dose-dependent decrease in peripheral red blood cell counts and
the change was significantly different in all treatment groups when compared to controls. A similar decrease was seen in leucocyte counts, but the
decrease was not significant. The cbange in packed
cell volume (PCV) exhibited a significant decrease
in the highest dose group (100 mg/L) only. From
the differential WBC counts shown in Table 30, it
can be seen that there was no treatment-related
effect on lymphocytes, neutrophils, and monocytes
when compared to the control group.
Table 31 shows tbe effect of a 4-week pbenol
exposure on the uptake of [3H]-thymidine by
mouse splenic cells. Exposure of mice to phenol
resulted in a significant depression of lymphocyte
blastogenesis in splenic cell cultures without
mitogen at all dose levels tested. There also
appeared to be a depressing mitogenesis response
to all selected mitogens i.e., LPS (a murine B-cell
mitogen), Con A (a T-cell mitogen), PWM (a Tand B-cell mitogen) and PHA (a T-cell mitogen).
From the uptake of [3H]-thymidine by mice
splenic lymphocyte cultures as shown in Table 31,
phenol exposure resulted in a significant suppres-'
sion of B lymphocyte blastogenesis in all dose
groups (LPS) and T lymphocyte blastogenesis in
the 20 and 100 mg/L groups (PHA) and in the 5
and 20 mg/L (Con A) groups. A similar trend was
also observed with PWM mitogens-stimulated
lymphoblastogenesis of splenic lymphocytes in all
dose groups.
The effects of various concentrations of
phenol exposure via drinking water on T-cell proliferation of mice splenic lymphocytes in response
to mixed lympbocyte culture are shown in Table
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32. A significant reduction of [3H]-tbymidine
incorporation occurred in allogeneic cell cultures in
all pbenol-treated mice splenic cells. Similar
responses were found in non-stimulated cultures
but tbere was no significant difference from
control. These findings show that phenol depresses T-cell function in response to allogeneic cells.
Results of StCr release assays suggest that
cell-mediated cytolytic response against tumor cells
was not affected by phenol exposure (Table 33).
After 4 weeks of phenol exposure via drinking water, the studies demonstrated that phenol
causes a statistically significant immunosuppressive effect at the two highest doses (20, 100 mg/L)
by decreasing the development of SRBC (sheep red
blood cell)-specific antibody plaque forming cells
(PPC) (Table 34). From the ELISA study, the
titer of a-SRBC antibodies was decreased significantly in the 20 and 100 mg/L dosed groups and
corresponded quite well with the reduction of
antibody production assessed by the number of
plaque-forming cells. 1bis a-SRBC response is a
primary immune response arbitrated by the IgM
class antibody.
Phenol-induced neurotoxicity in mice
At the doses administered. mice showed no
apparent clinical behavioral effects during the
period of tbese studies. After 4 weeks of phenol
exposure via drinking water, the levels of catecholamine and indoleamine neurotransmitters and their
major metabolites were measured in six different
brain regions. In most cases, phenol ingestion
caused a dose-related decreased response (Tables 35,
36, 37 and 38). Significant changes in these
selected neurotransmitters occurred in several bmin
regions. However, the effects were not often
exhibited in the lowest dose group (5 mg/L).
The greatest effect of phenol on ~he major
biogenic brain amines was in the hypothalamic
region. The concentration of norepinephrine (NE)
showed a significant decrease at the two higber
dose levels (20,100 mg/L). VMA, a major metabolite of NE, was influenced moderately QY phenol
exposure (TabJe 35). The indoleamine, 5-HT, and
its metabolite 5-HIAA were decreased significantly
in the high exposure groups [20, 100 mg/L] (Table
37). The hypotbalamic region is rich in these four
biogenic amines. Significant changes of dopamine
and its metabolite, DOPAC, in the hypothalamus
were not induced by phenol ingestion (Table 35).
The effects of phenol treatment were also
obvious in the corpus striatum region. The levels
of DA in this region were decreased significandy in

all treatment groups. The corpus striatum is a
brain region rich in DA (Table 36). The 5-RT
levels were significantly decreased in the highest
treatment dose (Table 38). The concentration of
VMA was also significantly decreased in the
100 mg/L group but its parent chemical, NE,
was not significantly decreased at this level (Table
36).
The concentration of 5-Hf was also significantly influenced by phenol exposure via drinking
water in the midbrain and medulla oblongata, the
regions containing relatively high amounts of this
amine (Table 37, 38). In other brain regions, the
levels of these seven selected neurotransmitters
were not significantly decreased, except for the
concentration of VMA in cortex, and showed a
dose-dependent response. The levels of HVA, the
last metabolite of DA, were not detected or low in
each group in the hypothalamus, meduJIa oblongata and cerebellum due to the fact that these three
brain regions contain relatively low amounts of
this chemical.
The results of these studies indicated that
phenol exposure via drinking water can induce a
decrease in the levels of all these selected neurotransmitters, and the concentration alteration may
be responsible for the reported encephalopathic
effect of phenol exposure (Windus-Podehl et al.,
1983).
Immunotoxic Effects of Benzene (200 mg/U,
Toluene <400 mglL) and a Mixture of Benzene
<200 mgIL) + Toluene (400 mgIL) in Mice
Continuous exposure of adult male CD-l
mice to benzene (200 mg/L), toluene (400 mg/L)
and a mixture of benzene (200 mg/L) + toluene
(400 mg/L) via drinking water for 4 weeks did not
produce overt clinical symptoms of toxicity in the
experimental animals. Overall, there was no
change in food and water consumption. At the termination of the study, no significant increase in
body weight gain was observed in the benzene (200
mg/L) only or mixture (200 mg/L benzene + 400
mg/L toluene) treatment groups when compared to
controls. However, there was a significant increase
in body weight gain in the toluene (400 mg/L)
only treatment group when compared to untreated
controls. The weight gain in this group was significantly different from that in the mixture group
(Table 39). In addition, the exposures resulted in
decreased spleen and thymus weights and increased
liver and kidney weights in all treatment groups.
Thymus weight showed a significant decrease in
the benzene (200 mg/L) only treatment group
when compared to controls (Table 40).
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The effects on selected hematological parameters of exposures to benzene, toluene and a
mixture of benzene + toluene are given in Table
41. Erythrocytes decreased significantly in the
benzene (200 mg/L) group when compared to
controls. In contrast, there was little change in
erythrocytes in the toluene (400 mg/L) and mixture
(200 mg/L benzene + 400 mg/L toluene) groups
when compared to controls. When compared to the
mixture group (Table 41), the decrease in
erythrocytes in the ben:r.ene only treatment group
was antagonized by toluene.

Erythrocytes increased significantly in the
mixture group when compared to the benzene only
treatment group. The blood leukocyte counts and
leukocyte differentials also exhibited similar
antagonized effects in the above treatment groups,
Exposures to mixtures of chemically related substances are frequently encountered. In such cases
the balance between different pathways of metabolism for chemicals could be radically changed
(Sipes and Gandolfi, 1986).
Toluene has been shown to alleviate benzeneinduced hematotoxicity (Andrews et al., 1977),
One possible explanation for this phenomenon is
that toluene competitively inhibits the biotransformation of benzene (Ikeda et al., 1972; Andrews
et al, 1977; Gilmour et al., 1986). However, the
toluene only treatment did not have a noticeable
effect on the selected blood parameters when compared to control animals.
Table 42 shows the effect of a 4-week
exposure on total spleen cellularity and the mitogen-induced splenic lymphocytic proliferations.
FoHowing 4 weeks of treatment, the proliferative
responses of either mitogen. stimulated or nonmitogen stimulated splenic lymphocytes were
depressed in the benzene (200 mg/L) and toluene
(400 mg/L) groups and increased in the mixture
group, but there was no statistically significant
difference between the toluene only treatment
group when compared to controls. Total spleen
cellularity revealed a similar phenomenon, but did
not change significantly in any of the treatment
groups.
The effects on T-cell proliferation of mice
splenic lymphocytes in response to mixed
lymphocyte culture (MLC) are shown in Table 43.
Inhibition of [3H]-thymidine uptake occurred in
allogeneic cell cultures in the benzene (200 mg/L)
and toluene (400 mg/L) treatment groups. In
contrast, [3Hl-thymidine uptake was elevated in the
mixture group. This response was also observed
in the "responder only" (non-stimulated) culture.

The results presented in Table 44 demonstrate
that exposure of mice to benzene (200 mg/L)
significantly impaired the capacity of the cytotoxic-T lymphocyte to lyse target cells (YAC-l
tumor cells) after 4 weeks of oral ingestion.
However, this response was antagonized by toluene
and showed a significant increase in the mixture
group. There were no significant depressions of
cytotoxic T -lymphocyte activity in the toluene
(400 mg/L) group when compared to the control
group..
The antibody production response to sheep
red blood cell (SRBC) assessed by enumeration of
the SRBC-specific plaque-forming cells (PFC) and
the alterations of a-SRBC antibody titers are
presented in Table 45. As shown in Table 45,
there was a marked change in the ability of treated
animals to produce SRBC-specific antibody. The
numbers of PFC showed a significant decrease in
benzene (200 mg/L) and toluene (400 mg/L)
treatment groups and a significant increase in the
benzene (200 mg/L) plus toluene (400 mg/L)
group. The a-SRBC antibody titer corresponds to
changes in numbers of PFC with a significant
increase in the benzene (200 mg/L) + toluene (400
mg/L) group.
Immunotoxic Effects of Benzene (200 mgIL),
Toluene <100 mglL) and a Mixture of Benzene
(200 mglL) + Toluene (100 mgIL) in Mice
Continuous exposure of adult CD-l mice to
benzene (200 mg/L), toluene (100 mg/L) and a
mixture of benzene (200 mg/L) + toluene (100
mg/L) via drinking water for 28 days was performed to evaluate the immunotoxic effects in COl mice.
There was no significant change in body
weight gain during the exposure period in all the
treatment groups when compared to the control
group (Table 46). Total food and water consumption was not affected in all treatment groups. The
relative organ weights for spleen and thymus decreased in the benzene only and mixture treatment
groups when compared to control animals.·
Thymus weight showed statistically significant
changes in these treatment groups compared to
controls (Table 47). Depression of spleen and
thymus weights was not observed in mice exposed
to 100 mg/L toluene. No changes in liver and kidney weights were found in all experimental groups
(Table 47).
Red blood cell counts were significantly
depressed in the benzene (200 mg/L) group when
compared to untreated controls. In contrast, a significant increase in RBC counts was found in the
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mixture group when compared to the benzene only
treatment group (Table 48) .. No differences in
spleen cellularities were detected except in the
group treated with 200 mg/L benzene, but this
depression was not statistically different from the
control group (Table 48).
Table 49 shows the effects of exposures to
benzene (200 mg/L), toluene (100 mg/L) and a
mixture of benzene (200 mg/L) + toluene (100
mg/L) on splenic lymphocyte proliferations to the
various mitogens. When compared to the untreated
controls, the DNA synthesis (cell proliferations) of
splenic cells was decreased in either non-mitogen
stimulation or mitogen stimulation in all treatment groups and showed a significant depression in
the 200 mg/L benzene (LPS, Con A), 100 mg/L
toluene (LPS), and the mixture groups (LPS, Con
A). However, no interaction effects on mitogenic
respon'lCs were found between the mixture and benzene or toluene treatment only groups.
The results of mixed lymphocyte responses
are shown in Table 50. A significant depression in
mixed lymphocyte responses was observed only in
the studies of responder-to-stimulator ratio at 2:1
and 4: 1 in all treatment groups when compared to
controls. There was also no interaction effects
observed in the mixture group when compared to
the benzene or toluene only treatment groups.
In conclusion, our immunotoxic studies of
benzene and toluene interactions in CD-l mice
have shown that a high dose of toluene (400 mg/L)
has remarkable alteration effects on the immunotoxicity of benzene at a 200 mg/L concentration
when administered in combination to adult, male
CD-I mice via continuous ingestion of drinking
water. The same alteration effects were not
observed with the low dose of toluene (100 mg/L)
in combination with benzene (200 mg/L).
Neurotoxic Effects of Benzene (200 mglL1
Toluene (400 mglL) and a Mixture of Benzene
(200 mglL) + Toluene (400 mgIL) in Mice
After 4 weeks of oral exposure via· drinking
water at the doses employed, no clinical behavioral
signs were observed in any of the treatment groups
including those animals exposed to a mixture of
benzene (200 mg/l) and toluene (400 mg/L).
In mice exposed to either benzene (200
mg/L), toluene (400 mg/L), or a mixture of benzene (200 mg/L) + toluene (400 mg/L), increased
levels of all selected neurotransmitters and their
major metabolites were detected in all brain regions
of every treatment group when compared to the
untreated controls. In most cases statistically significant increases of the major biogenic amines

studied were more often found in the various brain
region.'l analyzed than their metabolites (Tables 51,
52,53 and 54).
NE levels showed a significant increase in
hypotbalamus and medulla oblongata in all
treatment groups, cerebral cortex (benzene 200
mg/L), midbrain (benzene 200 mg/L) and
cerebellum (benzene 200 mgIL + toluene 400
mg/L). Significant increases of DA concentrations occurred in hypothalamus (benzene 200 mg/l,
benzene 200 mg/L + toluene 400 mg/L), cerebral
cortex (toluene 400 mg/L) and corpus striatum
(benzene 200 mg/L).

Significant increases of 5-HT levels were
observed in bypothalamus in all treatment
groups, cerebral cortex (benzene 200 mg/L,
toluene 400 mg/L), medulla oblongata (benzene
200 mg/L), corpus striatum (benzene 200 mg/L),
and midbrain (benzene 200 mg/L, toluene 400
mg/L).
ConcommitantJy with the increases of these
parent neurocbemicals, levels of each of their
major metabolites also increased significantly in
several brain regions. For example, there was a
significant increase of VMA in medulla oblongata
(toluene 400 mg/L, benzene 200 mg/L + toluene
400 mg/L), DOPAC in corpus striatwn (benzene
200 mgIL + toluene 400 mg/L), and HVA in
hypothalamus (benzene 200 mgIL, benzene 200
mg/L + toluene 400 mg/L), corpus striatum (benzene 200 mg/L, benzene 200 mgIL + toluene 400
mg/L), midbrain (benzene 200 mg/L) while the
levels of 5-HIAA were found significantly
increased in hypothalamus in all treatment. groups
and in midbrain (benzene 200 mg/L, benzene 200
mg/L + toluene 400 mg/L).
When compared to the benzene (200 mg/L) or
toluene (400 mg/L) only treatment groups, significant differences in levels of selected neurotransmitters were not often found in the mixture
(200 mg/L benzene + 400 mg/L toluene) treatment
group in the present studies. However, levels of
VMA were significantly different from those in
benzene (200 mg/L) only treatment in medulla
oblongata and in midbrain. DOPAC levels also
sbowed significant differences from those in
benzene (200 mg/L) only treatment in corpus
striatum.
Ne.yrotoxic Effects of Benzene (200 m gIL),
Toluene (100 mglL), and aMixture of Benzene
(200 mgIL) + Toluene (100 mglL) in Mice
Benzene (200 mg/L), toluene (100 mg/L) and
a mixture of benzene (200 mg/L) + toluene (100
14

mg/L) was continuously administered to adult CDI male mice via drinking water for 28 days, The
catecholamines, indoleamine and their major
metabolites in six brain regions were analyzed by
HPLC to evaluate the neurotoxic effects.
Similar to the exposure studies of benzene
(200 mg/L) + toluene (400 mgIL), the mice
exposed to either benzene (200 mg/L), toluene
(100 mgIL) or a mixture of benzene (200
mgIL) + toluene (100 mgIL) sbowed increased
levels of brain biogenic amines and their major
metabolites in an brain regions studied when
compared to the untreated controls (Tables 55, 56,
57, and 58).
NE levels showed a significant increase in
hypothalamus (toluene 100 mg/L), medulla
oblongata (benzene 200 mg/L), corpus striatum
(toluene 100 mg/L, benzene 200 mg/L + toluene
100 mg/L) and midbrain (benzene 200 mgIL).
Significant increases of DA were observed in
hypothalamus (toluene 100 mg/L) and in corpus
striatum (benzene 200 mg/L + toluene 100
mgIL). The 5-HT levels in medulla oblongata
(benzene 200 mgIL, toluene 100 mg/L) and in
midbrain (benzene 200 mgIL) also increased
significantly.

The major metabolites of selected
neurotransmitters increased in several brain
regions: 5-mAA in hypothalamus (benzene 200
mg/L), cerebral cortex (toluene 100 mg/L,
benzene 200 mg/L + toluene 100 mgIL) and
medulla oblongata (toluene 100 mg/L); DOPAC
in cerebral cortex (toluene 100 mg/L), medulla
oblongata (benzene 200 mg/L + toluene 100
mg/L), and corpus striatum (toluene 100 mg/L,
benzene 200 mgIL + toluene 100 mg/L); and
HVA in cerebral cortex (toluene 100 mg/L,
benzene 200 mg/L + toluene 100 mg/L), medulla
oblongata (all treatment groups) and corpus
striatum (all treatment groups).
Significant differences between benzene or
toluene treatment alone and the mixture exposure
group. as with the results of interaction studies of
benzene (200 mg/L) + toluene (400 mg/L), were
not often detected. Only the concentration of 5HIAA in hypothalamus and HVA in corpus
striatum of mixture group were found significantly different from the benzene only treatment.
The neurotoxic studie.~ of benzene and toluene
interactions in CD-I mice have shown that neither
a high dose of toluene (400 mgIL) nor a low dose
of toluene (100 mg/L) significantly alters brain
regional biogenic amines induced by benzene at
200 mg/L.

Swnmary and Conclusions

Groundwater is an important source of drinking water for approximately one-half of the U.S.
population. Numerous underground storage tanks
containing petroleum products may be leaking and
contaminating public water supply wells across the
U.S. Contamination of well water by petroleum
products from LUST is a matter of great importance. LUST pose a serious threat to the groundwater and public health. Many petroleum products
are known or suspected carcinogens or mutagens
which can cause adverse health effects. More
research on the types and concentrations of petroleum products occurring in public drinking water
well supplies, and the immunotoxic and neurotoxic
effects of these organic compounds is needed.
Wen water samples from five U. S.
Geological Survey shallow monitoring wells and
six deep drinking water wells in the vicinity of
petroleum refineries, gasoline stations, or other
activities (e.g., public works. steel manufacturing),
were collected during this project (919/85 to
/87). The volatile or semivolatile organic compounds detected in the shallow well water samples
by GC or Ge/MS analysis varied in concentration,
JJg/L (Tables 3 and 4). In addition to benzene,
toluene, ethylbenzene, and 2.-xylene which are
chemical constituents of gasoline, numerous other
organic compounds were detected by GC/MS
analysis (Table 5).

5n

Benzene, toluene, and phenol are major aromatic hydrocarbon compounds with environmental
and occupational significance (Hsieh, 1988). The
basic immunotoxic and neurotoxic effects of these
chemicals were evaluated in this study by utilizing
various imml1nological and neurological endocrinebiochemical parameters in CD-l mice
continuously exposed to nominal concentrations of
O. 40, 200. and 1,000 mg/L benzene, 0, 20, 100,
and 500 mg/L toluene and O. 5,20, and 100 mg/L
phenol in drinking water for 4 weeks. The
observed concentrations for benzene and toluene as
determined by gas chromatography were 0, 31,
166, and 790 mg/L, and 0, 17,80, and 405 mg/L,
respectively. The observed concentrations for
phenol were approximately 95 percent of the
nominal concentrations (0, 4.75,19, and 95 mg/L)
used.
Benzene exposure caused a dose-dependent
reduction in numbers of peripheral blood leukocytes, lymphocytes, erythrocytes and resulted in a
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severe macrocytic anemia. Splenic lymphocyte
proliferation to both B cetJ and T cell mitogens
(lipopolysaccharide, pokeweed mitogen, concanavalin A, and phytohemagglutinin) was followed by
a dose-related biphasic responsiveness, enhanced at
the lowest dose (40 mgIL) and depressed in the
higher dosage groups (200 and 1000 mg/L). Cellmediated immunity as measured by mixed-lymphocyte culture response to allogeneic cells and cytotoxic lymphocyte activity to YAC-I tumor cells
exhibited similar biphasic phenomenon. Antibody
production as assessed by enumeration of sheep red
blood cell (SRBC)-specific plaque-forming cells
(PFC) indicated a significant suppression of PPC
in animals exposed to 200 and 1000 mg/L benzene. A decrease in anti-SRBC antibody titer
corresponded to the numbers of PFC. The findings
indicate that oral ingestion of benzene produced a
biologically significant alteration in both hwnoral
and cellular immune responses.
Benzene also induced both synthesis and catabolism of regional brain monoamine neurotransmitters. In the hypothalamus, the brain region
richest in NE, concentrations of NE increased by
·50, 58, and 61 percent when mice received doses of
40, 200, and 1000 mg/L benzene, respectively.
Significant increases of NE were also observed in
the medulJa oblongata and cerebellum. Dopamine
concentrations increased significantly in the
hypothalamus and corpus striatwn. Increases of
catecholamine metabolites were seen in a number
of brain regions: midbrain (DOPAC), corpus striatum (VMA, DOPAC, HVA), cerebral cortex
(VMA) and cerebellum (VMA). Benzene treatment significantly increased 5-Hf concentrations
in the hypothalamus, corpus striatum, midbrain,
cerebral cortex and medulla oblongata. Concommitant with increases of 5-Hf, 5-IDAA increased
in hypothalamus, corpus striatum, midbrain, cerebral cortex and medulla oblongata.
Toluene is not as strong an immunotoxicant
as its analogue benzene. No effects on hematological parameters, including erythrocytes,
leukocytes and their differentials were noticed.
Splenocyte lymphoproliferations to alloantigens
decreased at the 500 mgIL toluene dose only.
Numbers of SRBC-specific PFC decreased in the
500 mg/L dosed animals, however, no significant
change was observed in anti-SRBC antibody level.
Toluene (500 mg/L) also adversely affected 1L- 2
synthesis. It appeared that suppression of immune

functions of mice ingesting toluene was generally
evident at relatively high doses, except for splenic
lymphocyte responses to selected mitogens,
The maximum toluene-induced increases in
brain biogenic amines and their metabolites
occurred at a toluene concentration of 100 mg/L. In
the hypothalamus, the concentrations of NE
significantly increased by 51, 53, and 34 percent in
groups dosed with 20, 100, and 500 mg/L toluene,
respectively. Increases of NE were also observed
in the medulla oblongata and midbrain. Correspondingly, concentrations of VMA increased in
various brain regions.
Concentrations of DA were higher in the
corpus striatum and hypothalamus. Alterations in
levels of the DA metabolites, DOPAC and HVA,
were marginal. Toluene increased 5-Hf in aU dissected brain regions except cerebellum, and 5HIAA levels in the hypothalamus, corpus striatum
and cerebral cortex. Noradrenergic and serotonergic
neurons appeared to be highly vulnerable to
toluene while dopaminergic neurons were rather
resistant.
The concentrations of hypothalamic NE and
VMA, plasma ACTH and serum corticosterone
were increased following both chemical exposures.
Comparisons of benzene-treated mice with
appropriate-time-controls revealed that corticosterone levels were significantly higher in mice after 7
days (200 and 1000 mg/L benzene) and at 28 days
(1000 mg/L of benzene). Toluene elevated corticosterone levels at 14 and 28 days at the 500 mg/L
exposure. IL-2 production was suppressed in the
two higher benzene-treated groups, while toluene
decreased IL-2 synthesis at the 500 mg/L concentration only.
Results indicated that both benzene and
toluene ingestion stimulated the hypothalamicpituitary-adrenocortical (HPA) axis, resulting in
elevation of corticosterone which has been reported
to inhibit IL-2 production and impair immunocompetence.
Phenol exposure, like the benzene exposure,
caused a dose-dependent decrease in peripheral
erythrocytes and leucocytes. Splenic lymphocyte
proliferation to both B cell and T cell mitogens
(LPS, PHA, Con A and PWM) also resulted in a
significant suppression in the higher dosage groups
(20 and 100 mg/L). Cell-mediated immunity as
measured by mixed-lymphocyte culture response to
allogeneic cells exhibited a biphasic response enhanced at the lowest dose (5 mg/L) and depressed in
the higher dosage groups (20 and 100 mg/L).
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Phenol depresses T-cell function in response to
allogeneic cells. Antibody production as assessed
by enumeration of sheep red blood cell (SRBC)specific antibody plaque-forming cells (PFC)
showed a significant immunosuppression of PFC
in animals exposed to 20 and 100 mg/L phenol.
Phenol caused a dose-related decrease in
regional brain monoamine neurotransmitters in
several brain regions. The greatest effect of phenol
on the major biogenic brain amines was in the
hypothalamic region. NE showed a significant
decrease at the two highest dose levels (20 and 100
mg/L). Likewise, the indoleamine, 5-Hf, and its
metabolite 5-HIAA were significantly decreased in
the high exposure groups.
In the corpus striatum, a brain region which
is rich in DA, levels of this neurotransmitter were
significantly decreased in all treatment groups as
were 5-HT and VMA levels in the highest treatment group (100 mg/L). Phenol exposure via
drinking water can induce a decrease in the levels of
selected neurotransmitters and the concentration
alteration may be responsible for the reported
encephalopathic effect of phenol exposure.
The interactions of benzene and toluene were
also evaluated in this study by utilizing various
immunological and neuroendocrino-biochemical
parameters in CD-1 mice continuously exposed to
0, 40, 200, and 1000 mg/L benzene and 0, 20,
100, and 500 mg/L toluene, respectively, in
drinking water for 4 weeks. The toxicity of
environmental pollutants such as benzene and
toluene may be expressed as combined effects of
the chemicals. Benzene frequently occurs in a cocontaminated environment with toluene, a competitive inhibitor of the biotransfonnation of
benzene. When co-administered with benzene (200
mg/L) , toluene (400 mg) completely inhibited
benzene-induced immunotoxicity, i.e., involution
of thymic mass and suppressions of both B- and Tcell mitogeneses, mixed lymphocyte culture
response to alloantigens, the ability of cytotoxic
lymphocytes to lyse tumor cells, antibody production respon~e to SRBC, and IL-2 secretion by Con
A-stimulated mouse T-cells. However, the low
dose oftoluene (100 mg/L) did not protect against
benzene-induced depressions of immune function.
The results demonstrate that toluene, in sufficient
amounts, has an antagonistic effect on benzene
immunotoxicity. When compared to the untreated
controls, mice given the combined treatments of
benzene and toluene exhibited elevated regional
concentrations of brain amines and their metabolites in several brain regions. Increased concentrations of biogenic amine metabolites in a few brain
regions were greater in the combined exposures of

benzene and toluene than when either chemical was
used alone; there was a marginal additive effect
between these two types of neurotoxic ants.
The present study demonstrates that benzene,
toluene, and phenol possess the potential for
inducing immunotoxic and neurotoxic effects in
CD-I mice following 4 weeks of continuous exposure via drinking water. Of particular importance
was the fact that neurotoxic effects were evident
at the lowest dose of benzene or toluene treatment,
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and a no-effect level could not be established.
Further studies involving lower levels of exposure
of environmental pollutants are necessary to fully
ascertain the safety of these compounds in drinking
water. The results of combination studies suggest
that benzene immunotoxicity is mainly due to
action ofthe reactive metabolites, whereas benzene
neurotoxicity results from benzene itself. In
addition, both benzene and toluene have, at least
partially, an additive negative effect on immune
function via the activated HPA axis.
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Application of Research Results

Since this research project was approved and
initiated on June 25, 1985, several agencies have
expressed an interest in receiving data on the
characterization and concentrations of organic
chemicals detected in well water. The Davis
County and South Salt Lake City Health
Departments and the Bureau of Public Water
Supplies, Division of Environmental Health, State
of Utah Department of Health, would like to use
the results to assist them in deveJopment of
groundwater quality standards, to help pinpoint
leaking underground storage tanks and to support
efforts for protection of groundwater drinking water
supplies and public health. Others who could
make use of data produced by this project include
the USGS, USEPA, Utah Bureau of Solid and
Hazardous Waste, petroleum refining industries,
and universities, among others.
Although there is a large amount of information available detailing the effects of benzene on
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the hematopoietic system, studies concerning the
immunotoxic evaluations of this chemical are
scant. Also, little information is available
regarding the effects of toluene exposure on immune systems. In addition, despite several published studies about the positive effects of benzene
and toluene on behavioral changes, research
conducted on the neurotoxic potential, (i.e., alterations in brain neurochemicals), is still limited.
little research has been done on the chronic effects
of long-term exposure to trace levels of organic
chemicals detected in drinking water (Varma et al.,
1976). The research results will provide toxicologists and other researchers with more information for better understanding the mechanisms
and rates at which petroleum compounds impact
human health, especially long-term health effects
(i.e., immunotoxic and neurotoxic) of exposure to
low levels of these organic compounds in drlnking
water obtained from contaminated public well
water supplies.
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TABLE 1.

Temperature, pH, and Conductance Values Of Well Water Collected from USGS Shallow
Monitoring Wells During the September 9,1985 to April 24, 1987 Sampling Period.

Shallow Well
Water Samplest

Sampling Dates

1987
1986
1985
9·912·1012·16 12·17 2.6* 3·3 6·10 10·31 2·3 2·14 2·20 3·16 4·24
Sample 1
Temperitture(°C)tt 17.0 10.0
pll·

Conductance·'"

6.8
6.6

7.8 7.8
47175105

-

17.0 12.8
7.8 7.4
4104

(J.Ullhoslcm)

Sample 2
TemperatureeC)tt 18.0
pH'"
7.0

13.0

Conductance"'·

2306

1546

10.5 15.7

16.0

6.6

6.9 6.9
2277

7.23

11.0

9.7

12.0 13.3

13.9

10.4

10.0

10.6

7.4
1662

6.5

6.6 6.9
1567

5.5

6.9

7.0

7.0

16.7

10.4

8.5

10.7

5.5

7.1

6.8

7.2

10.6

6.6

(f.UJlhos/cm)

Sample 3
Temperature(OC)tt 16.0
pH'"
6.8

Conductance"''''

1339

(f.UJlbos/cm )

Sample 4
Temperature(°C)tt
pH·

Conductance"'·
(pmhos/cm)

Sample 5
Temperatureec)tt
pH·

11.6
7.6···

Conductance"'·
(pmbos/cm)
t

Well water sample number: Sample I collected at a private residence at 3138 N. 2450 W., North Salt
Lake City, Utab; Sample 2 at a private residence at 5549 South Redwood Road near Murray~Utah;
Sample 3 at the Sandy Public Works Dept. at 8775 S. 700 W., Sandy, Utah: Sample 4 at 7000 S.
2000 E., Salt Lake City, Utah, just north of a Sinclair gas station; and, Sample 5 at the La Manns
Apartments at 4500 S. 945 E., Salt Lake City, Utah.
tt Temperature measured with a dry bulb tbennometer, or an Orion SA 250 meter.
• pH measured with Hydrion paper or an Orion SA 250 meter
0

• '" Conductance measured with YSI Model 33 S-C-T meter and corrected for condition at 25 C.
• "'. Sediment masked color development.
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TABLE 2.

Temperature, pH. and Conductance Values Of Well Water Collected from Deep Wells During
the November 8, 1985 to May 7, 1987 Sampling Period.

Deep Well
Water Samplest

Sampling Dates

1985
11·8
Sample 6
Temperature(oC)tt
pH·
Conductance

••

2·1

2·2

2·6

1986
5·31

6·1

15.0
6.6

13.5
6.5

19.4
6.7

15.6
6.5

13.4
6.5

19.2
6.6

6·5

6·10

1987
4·24 5·7

(J.lmhos/cm)
Sample 7
Temperature(°C)tt
pH·
Conductance ••
(J.U11hos/cm)

Sample 8
Temperature(°C)tt
pH·
Conductance··
(J.1Illhos/cm)

13.7
6.5

16.1
6.6

Sample 9
Temperature(°C)tt
pH·
Conductance··
(Ilmhos/cm)
Sample 10
Temperature(°C)tt
pH·

12.8
6.2

13.6
6.5

17.2
7.1
1127

14.4
7.4

14.2
6.9

17.0
7.3
1179

Conductance··
(Ilmhos/cm)
Sample 11
Temperature(°C)tt
pH*
Conductance··
(Ilmhos/cm)

16.7
6.2

t

19.4
6.6

Well water sample number: Sample 6 and 7 were collected at private residences at Pelican Point, Utah,
west side of Utah Lake; Sample 8 at dairy farm, 17 Vineyard, S. of U.S. Steel··Geneva Works,
Orem, Utah; Samples 9 and 10 from pasture west ofCrysen Oil Refinery, 2355 S. 1100 W., Woods
Cross, Utah; and Sample 11 at a private residence at 3215 N. 2450 W., North Salt Lake City, Utah.
ttTemperature measured with a dry bulb thermometer, or an Orion SA 250 meter.
• pH measured with Hydrion paper or an Orion SA 250 meter.
•• Conductance measured with YSI Model 33 S·C·T meter and corrected for condition at 25°C.
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TABLE 3. Volatile Organic Compounds Detected by GC Analysis in Water Collected From Shallow Monitoring Wells Numer 1,2,3,4 and 5t.
COMPOUND CONCENTRATION (J.tgfL)

Compound
Benzene
Toulene
Ethylbenzene
p-Xylene
1,3,5-Trimethylbenzene
1,2,3,4-Tetramethylbenzene
1,2,4,5-Tetramethylbenzene
1-Methylnaphthalene

WeUNumber I
9/9/85
9/9/85
P&T
MCE
0.05

9/9/85
P&T

9/9/85
MCE

2/6/86
P&T

WeUNumber2
2/6/86
6/10/86
MCE
~T

6/10/86
MCE

4/24/87
~T

4/24/87
MCE

17.98
0.32

5.95
1.13

9.57
0.90
4.96

~

COMPOUND CONCENTRATION (J.tgfL)

Compound
Benzene
Toulene
Ethylbenzene
p-Xylene
m-Xylene
o-Xylene
1,3,5-Trimethylbenzene
1,2,3,4-Tetramethylbenzene
1,2,4,5-Tetramethylbenzene
I-Methylnaphthalene
Naphthalene

~

q

fl!

9/9/85 9/9/85 2/6/86 2/6/86
MCE
P&T
MCE
P&T
34.00

13.70 31.01
4.19
53.17
7.79

4.82
1.87
53.23
0.48

6/10/86 6/10/87
P&T
MCE
93.29
101.27

12.23
5.83
8.92

1.94

1.27

WeU Number 3
2/3/87 2/3/87 2/20/87 2/20/87
P&T MCE
P&T
MCE

112.27
122.01
23.47
8.67
17.89 96.43 36.21 74.36
25.26
26.99
0.29
0.31
55.55
7.03
8.90
13.96
5.48
5.18

4.14

1.83
20.98

15.22

3/16/87 3/16/87 5n/87 5n/87
P&T
MCE
P&T MCE
71.43
4.01
83.15
13.67
2.58
62.45
9.49
10.46

8.87
8.70
44.93

19.34

0.81

TABLE 3. Volatile Organic Compounds Detected GC Analysis in Water Collected from Shallow Monitoring Wells Number 1,2,3,4 and 5t (cont.).
COMPOUND CONCENTRATION (p.g/L)

Compound

N

00

Benzene
Toulene
Ethylbenzene
p-Xylene
o-Xylene
m-Xylene
1,3,5-Trimethylbenzene
1,2,3,4-Tetramethylbenzene
1,2,4,5-Tetramethylbenzene
1-Methylnaphthalene
Naphthalene

2/3/87

2/3/87

P&T

MCE

Well Number 4
2/14/87
2/14/87
P&T
97.58
57.70
2.13
6.50
0.81
2.49
2.68

MCE

3/16/87

3/16/87

P&T

MCE

18.23
3.53

Well Number 5
2/14/87
2/14/87
P&T

MCE

196.83
122.33
5.55
14.54
3.08
8.36
6.70

2.66

6.90

3.36

4.81

t Well water sample number: Well number 1 water sample collected at a private residence at 3138 N. 2450 W., North Salt Lake City, Utah; Well number 2
water sample collected at a private residence at 5549 South Redwood Road near Murray, Utah; Well number 3 water sample collected at the Sandy Public
WOJ:k:s Dept. at 8775 S. 700 W., Sandy, Utah; Well number 4 water sample collected at 7000 S. 2000 E., Salt Lake City, Utah, just north of a Sinclair gas
station; and Well number 5 water sample collected at the La Manns Apartments at 4500 S. 945 E., Salt Lake City, Utah.
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TABLE 4. Organic Compounds Quantified by GCIMS Analysis in Water Collected from Shallow Monitoring Wells Number 3 and 4.
COMPOUND CONCENTRATION (p.g/L)

Compound

NI
\0

1,2,3,4-Tetramethylbemene
1,2,3,5-Tetramethylbemene
1,2,3-Trimethylbemene
1,2,4-Trimethylbemene
l-Ethyl-2-methylbemene
l-Ethyl-4-methylbemene
l-Ethylnaphthalene
I-Methylnaphthalene
2,3-Dihydro-1H-indene
Benzene
Diethylbemene
Ethylbemene
Ethylmethylbenzene
Naphthalene
Propylbenzene
Toluene
Trlmethylbenzene
Xylene

213/87
MCE

213/87
MCE

11.58
15.32

12.68
16.91

Well Number 3
2/20/87
3/16/87
MCE
MCE

3/16/87
MCE

5n/87
P&T

5n/87
P&T

Well Number 4
213/87
MCE

29.84
5.78
15.45

3.67

6.26

0.33

2.31
1.79

3.28

0.01
4.58
1.20
119.5

0.06
10.69

0.48
12.37

13.61
0.12
2.89
51.69

16.43
0.13
3.56
55.02

0.33
45.01

39.73

42.23

0.58
161.70
56.24

273.70
43.21

21.63
39.89

1.04

1.40

1.05

494.40
33.12

676.10

8.20
0.01

1.47
34.86
5.13
1.19
0.11
0.38

738.80 .

1.87
0.83

1.02

t Well water sample number: Well number 3 water sample collected at the Sandy Public Works Dpt. at 8775 S. 700 W., Sandy, Utah; and Well number 4
water sample collected at 7000 S. 2000 E., Salt Lake City. Utah, just north of a Sinclair gas station.
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TABLE 5. Compounds Detected by GC/MS analysis of Shallow Monitoring Well Water Samples
AnaJyzed in tbe Study.
Extraction/Concentration Metbods
Purge and Trap

Metbylene Chloride Extract

( I-Metbyletbyl)benzene
1,1,1 -Trichloroetbane
1,2,3,4-TetrabydronaphtbaJene
1,2,3,4-Tetrametbylbenzene
1,2,3,5-Tetrametbylbenzene
1,2,3-Trimetbylbenzene
1,2,4-Trimetbylbenzene
I,3-DiethylbeD7.ene
I-Ethyl-2-metbylbenzene
I-Etbyl-4-(I-metbylethyl)benzene
l-Etbyl-4-metbylbenzene
I-Etbylidene-IH-indene
I-EtbylnaphtbaJene
1-Metbyl-2-propyl-benzene
I-Methyl-4-(I-metbyletbyl)benzene
1-Metby 1-4-propylbenzene
I-MetbyloaphthaJene
I-Pentylcyclohexane
2,3-Dibydro-I ,3-dimethyl-IH-indene
2,3-Dibydro-l-metbyl-IH-indene
2,3-Dibydro-IH-indene
2,3-Dibydro-4,6-dimetbyl-IH-indene
2-Chloro-I-phenylethanone
2-Ethy1-1 .3-dimetbylbenzene
2-Etbyl-I,4-dimethylbenzene
3,4-Dimethyl-I-hexane
5-Methyl,(Z)-4-undecene
Benzaldehyde
Benzene
Dichlorometbane .
Diethylbenzene
Etbylbenzene
Metbylenepropanedinitrile
NaphtbaJene
Oxybis[dichloro]methane
Propylbenzene
Toluene
Trichlorometbane
Xylene

(I,I-Dimethyl-2-propenyl)benzene
(2-Metbyl-2-propenyl)benzene
(2-Propenyloxy )-benzene
1,3,5-Trimetbylbenzene
1-Etbenyl-2-metbylbenzene
l-Etbenyl-3,5-dimetbylbenzene
I-Etbenyl-3-etbylbenzene
I-Metbyl-2-(2-propenyl)benzene
I-MetbyloaphtbaJene
1-Etby 1-2-metbylbenzene
IH-Imidizole-2-carboxaldehyde
2-Chlorocyclobexanol
2,3-Dibydro-I,I,3-trimethyl-3-phenyl-IH-indene
2,3-Dibydro-l-metbyl-l H-indene
2,3-Dibydro-IH-indene-I-one
2.3-Dibydro-IH-indene
2,3-Dibydro-2-methyl-IH-indene
2-Etbyl-I ,4-dimethylbenzene
2-[(phenylmethyl)amino ]etbanol
3-Metbylundecene
Benzo[B]tbiophene
Bis(2-etbylhexyl)phtbalate
DibutylphtbaJate
Dietbylbenzene
Dimetbylethylbenzene
Etbylbenzene
Etbylmetbylbenzene
Iso-propyJbenzene
Metbylpropylbenzene
Metbylundecene
NaphtbaJene
Propylbenzene
Sulfur dioxide
Sulfur
Tetrametbylbenzene
Toluene
Trimetbylbenzene
Xylene
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TABLE 6. Effect of Benzene Exposure on Body Weight Gain
Concentration in water/mg/l
Nominal

Observed

Dose
(mg/kglday)

Body Weight Gain
(gm)a

0

0

0
(control)

7.82± 0.91 a

40

31

8

7.26 ± 1.68

200

166

40

9.04 ± 1.10

1000

790

180

9.12 ± 1.66

aValues are given as mean ± S.D. (n=5).
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TABLE 7. Organ and Body Weight of CD-I Mice Following 4 Weeks of Benzene Exposurea
Body Weight (g)b

Concentration in water (mg/L)
Nominal

Observed

Doses
mglkg/day

Day 0

Day 28

Organ weight (g/lOOg body weight)b
Spleen

Liver

Kidney

Tbymus

0

0

0

23.20±O.37

31.22±O.62

0.33±0.02

5.57±0.13

1.55±0.06

0.16±O.02

40

31

8

22.68±O.33

29.94±O.98

0.30±0.01

5.46±0.29

1.58±0.08

0.12±O.0l

200

166

40

23.74±O.22

32.98±O.65

0.28±O.01

5.86±O.70

1.65±0.10

0.12±0.0l

1000

790

180

23.14±O.29

32.26±O.86

0.26±O.01*

S.98±O.20

1.87±O.05*

0.11±0.0l

!.;l

N

~enzene was administered continuously via drinking water for four weeks.

bvalues are given as mean ± S.B. (n = 5).
*Significantly (p < 0.05) different from control (0 mg/L) values.
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TABLE 8. Effect of Benzene Exposure on Spleen Cellularity and Selected Blood Parametersa•
Leukocyte absolute differentials

Dose·
(mg/L)

\,j..l
\,j..l

Spleen Cell No.
(dO·')

Erythrocytes

Hematocrit

(l0·6/mm 3)

(%)

MCV**
(tl)

Leukocytes
(10-3jmm3)

Lymphocytes

Neutrophils

OIhers***

(l0·2jmm3)

(10-2/m m3)

(l0-2jmm3)

0

7.5I±O.40

7.01±O.65

50.30±0.58

74.01±6.03

5.96±0.60

43.75±5.23

1O.97±1.33

4.49±0.78

40

7.91±O.62

4.57±O.28b

48.80±0.46

108.30± 6.49b

4.23±0.07b

29.94±O.70b

8.49±1.03

3.77±0.54

200

7.50±0.41

3.68±O.65b

46.20±0.46b

125. 18±15.68b

4.22±0.57b

23.48±3.04b

14.60±2.42

3.97±0.92

5.17±O.64b

3.43±O.39b

45.00±1.22b

136.76±12.57b

2.87±0.16b

16.06±2.02b

10.16±O.74

2.47±0.93

1000

=

a Values are given as mean ± S.E. (n 5).
b Significantly (p < 0.05) different from control (0 mg/L) values.
* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks.
**Mean corpuscular volume.
***Including monocytes, eosinophils and basopbils.,

TABLE 9. Effect of Benzene Exposure on Splenic Lymphocyte Proliferative Response to Mitogens.
Mitogenic responses··
Dose*
(mg/L)

None

200

1.68±0.31 a
3.55±0.89b
1.13±0.13

1000

0.91±0.19

0
40

LPS

PWM

ConA

PHA

102.04±23.66
261.23±25.62b
22.43±3.48b

7.45±1.90
12.92±2.19b
3.25±O.71

154.69± 49.33
384.90±1 08.61 b

68.02±18.57
258.81±88.01 b

29.30± 7.69b

16.43±3.94b

3.65±O.72

14.61± 2.66b

8.87±1.83b

25.44±6.20b

* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks.
** dpm/106 splenic cells (xlO- 3): response evaluated by incorporation of [methyl- 3H]-thymidine into day 2
splenocyte cultures for 6 hours pulsing.
a Values are given as mean ± S.E. (n=5).
b Significantly (p<0.05) different from control (0 mg/L) values.

TABLE 10. Effect of Benzene Exposure on Mixed Lymphocyte Response.
DPM/l06 cells (xl 0-3 ) **
Doses·
(mg/L)

Responders

Responders + Simulators

0
(Control)

2.77±O.30

31.49±2.77

40

3.59±0.87

56.24±1.59a

200

1.71±O.42

18.77±2.36a

1000

1.58±0.18

9.30±O.88 a

* Ben7.ene was administered continuously to CD-I mice via drinking water for 4 weeks.
** Responder cells were the syngeneic splenic cells of CD-I mice and stimulator cells were the allogeneic
Yac-l cells. A ratio of two stimulators to one responder was used, and the stimulator cells were treated
with mitomycin-C before addition to the culture. MLC evaluated by incorporation of [methyl-3 H] thymidine into day 3 MLC cultures for 6 hours pUlsing. Values are given as mean ±S.E. (n = 5).
a Significantly (p < 0.05) different from control (0 mg/L) values.
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TABLE 11. Effect of Benzene Exposure on Cytotoxic T-Lymphocytes (CIL) Response.

% Cytotoxicitya
Dose*
(mg/L)

25:1

50:1**

0
(Conttol)
40

15.72±1.16

15.98±2.98

17.94±1.61

23.32±2.05b

200

8.77±L87b

1000

5.82±O.94b

11.09±1.71
9. 17±1.53b

* Benzene was administered continuously to CD-I mice in drinking water for 4 weeks.
** Effector (day 5 MLC lymphocytes) -to - target (51Cr labelled Yac-l cells) cell ratio.

a Values are given as mean ± S.E. (n = 5).
b Significantly (p <0.05) different from control (0 mg/L) values.

TABLE 12. Effect of Benzene Exposure on the Antibody Responses to Thymic-Dependent Antigen Sheep
,..
Erythrocyte (SRBC) .

,..,..
Spleen cell No

PFC/106

PFC/totalSpleen cells

(xlO~

Splenic cells

(x10~

Antibody.Titer

0

22.59±3.02

1.254±17a

295.72±74.5l

0.44±O.06

8

16.80±1.59a

1.576±65

268.80±36.10

0.57±O.11

40

·15.36±0.65a

643±49a

99.76±10.32a

0.31±Q.05

180

l2.70±1.51 a

229±40a

31.4l± 9.52a

0.21±0.0I a

Dose

(ms'Kglday)

a-SRBC

* Mice were sensitized with SRBC 4 days before the end of the benzene exposure. Splenic lymphocytes
were analyzed for antibody forming cells (plaque-fonning cell, PFC) and sera were detected for antibody
titer (a-SRBC) detennined in sera. Values are given as mean ± S.E. (n = 5).
** Benzene was administered continuously to CD-I mice in drinking water for four weeks.
a Significantly (p < 0.05) different from conttol (0 mg/L) values.
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TABLE 13. Effect of Benzene on Regional Brain Catecholamines *.
Brain Regiona
Catecholamineb

NE

VMA

DA

DOPAC

HVA

Dosesc
(mg/L)

MeduUa Oblongata

Hypothalamus

CerebeUum

1000
200
40
0

1.63±0.lS*
1.60±0.22*
1.27±0.11
O.96±0.08

O.71±O.Ol
0.78±O.03*
0.69±O.OS
0.61±O.03

0.38±O.03*
0.33±O.02
O.29±O.03
0.26±O.OS

1000
200
40
0

0.4O±0.03
0.37±0.OS
0.30±0.04
0.26±0.02

O.24±O.Ol
O.24±O.Ol
0.24±O.01
0.19±O.03

0.28±O.01*
0.23±O.01*
0.24±O.02*
0.19±O.01

1000
200
40
0

0.4S±O.OS
0.49±O.11
O.41±O.OS
0.30±0.OS

0.04±O.00
O.OS±O.Ol
0.08±O.02
O.OS±O.Ol

0.03±O.01
0.03±O.01
0.04±O.02
O.04±O.Ol

1000
200
40
0

0.13±0.02
0.16±0.02*
0.08±0.01
0.10±0.02

0.07±O.00
0.08±O.01*
0.08±O.01*
O.OS±O.Ol

0.07±O.01
O.O6±O.Ol
O.OS±O.Ol
0.04±0.01

1000
200
40
0

0.07±0.03
0.1l±0.02
0.13±0.02
0.09±O.03

O.OS±O.OO
0.06±O.01
0.07±O.01
O.OS±O.Ol

0.03±0.00
0.03±O.00
0.OS±0.02
0.02±0.01

a Ilg brain biogenic amines/g wet tissue (mean ± S.E.)
b NE: Norepinephrine; VMA: Vanillylmandelic acid; DA: dopamine; DOPAC: dihydroxyphenylacetic
acid; HVA: homovaniUic acid.
C Doses were administered continuously to CD-I mice in drinking water daily for 4 weeks.
* Significantly (p < O.OS) different from control (O mg/L) values.
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TABLE 14. Effect of Benzene on Regional Brnin Catecholamines.
Brnin Region8
Catecholamine

NE

VMA

DA

DOPAC

HVA

Dosesc
(mg/L)

Midbrain

1000
200
40
0

0.72±0.03*
0.62±O.03*
0.6S±O.02*
0.4S±O.OS

0.34±O.04
0.36±O.03
0.27±O.02
0.33±O.07

0.S2±O.02
O.72±O.OS*
0.S3±0.20
0.34±0.OS

1000
200
40
0

O.27±O.03
0.2S±O.02
0.29±O.02
0.23±O.O3

0.30±O.04*
0.29±O.01*
0.2S±O.03*
0.20±O.03

0.29±0.01*
0.3S±0.04*
0.28±O.03*
0.17±0.02

1000
200
40
0

0.25±0.OL
0.21±O.02
0.23±0.03
0.19±O.01

S.88±O.66
S.IS±O.72
7.2S±O.35
6.S9±O.Sl

1.1l±0.06
1.64±0.23
1.62±O.44
0.87±O.09

1000
200
40
0

0.15±O.01*
0.15±O.01 *
O.lS±O.Ol*
0.11±0.01

1.04±O.09*
0.S4±O.06
0.7J±O.02
0.71±O.09

0.2J±0.01
0.30±0.03*
0.2S±O.05*
0.14±O.02

1000
200
40
0

O.lS±O.Ol*
0.14±O.01*
0.19±O.01*
O.l1±O.Ol

1.04±O.10*
0.97±O.09
0.S7±O.06
0.73±O.OS

0.22±O.01
0.30±0.04*
0.29±O.06*
0.14±0.01

Corpus Stradum

Cortex

J1g brain biogeoic amines/g wet dssue (mean ± S.B.).
b NE: norepineptuine; VMA: Vaoillylmaodelic acid; DA: dopamine; DOPAC: dihydroxyphenylacedc
acid; HVA: homovanillic acid.
C Doses were administered condouously to CD-I mice in drinking water daily for 4 weeks.
* Significantly (p < 0.05) different from control (0 mg/L) values.
8
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TABLE 15. Effect of Benzene on Regional Brain Indoleamines.
Brain Region8
Indoleamineb

c
Doses
(mgIL)

1000
S-Hf

200
40
0
(Control)

1000

S-HIAA

200
40
0
(Control)

Medulla Oblongata

Hypothalamus

Cerebellum

0.SI±0.12
1.03±0.IS
0.SS±0.12
O.63±O.1O

0.S4±O.03
0.S2±0.03
0.94±0.OS*
0.76±O.OS

0.31±O.O4
0.23±O.02
0.27±O.03
0.23±O.03

0.44±0.09
0.40±0.07
O.4S±O.10
O.26±O.03

0.34±0.02
0.29±O.O2
O.3S±O.02
0.30±O.02

0.J2±O.02
O.OS±O.OO
0.10±O.02
0.09±O.01

a Ilg brain biogenic amines/g wet tissue (mean ± S.E.).
b S-Hf: S-hydroxytryptamine (serotonin); S-HIAA: S-hydroxyindoleacetic acid.
c Doses were administered in drinking water daily for 4 weeks.

* Significantly (p < O.OS) different from control (0 mgIL) values.

TABLE 16. Effect of Benzene on Regional Brain Indoleamines.
Brain Region 8
Indoleamineb

S-Hf

S-HIAA

Dosesc
(mgIL)

COIpUS Stratium

Midbrain

Cortex

1000
200
40
0
(Control)

1.07±0.02*
1.04±0.03*
1.0S±O.06*
0.Sl±0.08

0.70±0.06
0.80±O.O3
0.70±0.04
0.61±O.OS

0.89±0.OS
1.31±O.17*
1.34±O.2S*
0.S7±0.06

1000
200
40
0
(Control)

0.52±O.02*
0.40±0.01*
0.Sl±O.03*
0.33±O.03

0.39±0.03
0.40±0.02
0.32±0.03
0.30±0.OS

0.26±0.02*
0.31±0.04*
0.33±0.OS*
0.14±O.02

Ilg brain biogenic amines/g wet tissue (mean ± S.B.).
b S-Hf: S-hydroxytryptamine (serotonin); S-HIAA: S-hydroxyindoleacetic acid.
C Doses were administered in drinking water daily for 4 weeks.
* Significantly (p < O.OS) different from control (0 mgIL) values.
8

38

TABLE 17. Effect of Toluene Exposure on Body Weight Gain in CD-I Mice.
Concentration in water, mg/L

Nonninal

Dose
(mg,'kg/day)

ObselVed

Body Weight Gain
(gm)a

0

0

0
(Control)

14.24

± 2.52

20

17

5

13.70

± 1.42

100

80

22

13.02

± 1.05

500

405

105

a Values are given as mean ± S.D. (n

=5).
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15.14 ± 1.59

TABLE 18. Organ and Body Weight of Mice Following Toluene Exposure
Body Weight (g)b

Organ Weight (g/100 g body weight)b

Dosea
(mg/L)

.J>.

0

Day 0

Day 28

Spleen

Liver

Kidney

Thymus

0

20.62±O.13

34.86:H.18

0.34±0.03

5.67±O.07

1. 62±0. 05

0.19±O.02

20

20.56±O.02

34.26±0.64

0.31±0.01

6.09±O.17

1. 72±0. 06

0.18±O.01

100

20.16±O.31

33. 18±O.21

0.33±O.01

6.32±O.17

1.68±O.03

0.18±O.02

500

20.00±0.23

35. 12±O.72

0.28±O.01

6. 73±0. 14*

1. 68±O.05

0.13±0.02*

a Toluene was administered continuously to CD-I mice in drinking water for 4 weeks.
b Values are given as mean ± S.B. (n = 5).
... Significantly different from control values at p < 0.05.
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TABLE 19. Effect of Toluene Exposure on Spleen Cellularity and Selected Blood Parametersa.
Leukocyte absolute differentials
Doseh

Erythrocyte
(106/mm 3)

Leukocyte
(10 3/mm3)

Lymphocyte
(103/m m3)

Neutrophil
(l03/mm 3)

(l03/mm 3)

7.71±0.27C

9.30±0.26

5.96±l.02

4.40±0.62

1.13±O.38

O.4I±0.08

20

6. 18±O.52

9.87±O.49

6.34±O.57

4.46±O.38

1.46±O.39

0.42±O.09

100

6.57±O.91

8.79±O.85

6.43±O.57

4.50±0.78

I.42±O.48

O.50±O.07

500

6.58±0.47

9.38±O.38

3.90±O.36

2.81±0.32

O.82±O.I6

0.36±0.05

(mg/L)

o

-

Total
Splenocyte
(x 10-7)

.t:.

=

a Values are given as mean ± S.E. (n 5).
b Toluene was administered continously to CD-I mice in drinking water for 4 weeks.
c Including monocytes, eosinopbils and basophils•

.,

Othef

TABLE 20. Effect of Toluene Exposure on Splenic Lymphocyte Proliferative Response to Mitogens.
Mitogenic responses**
Dose*
(mg/L)

None

LPS

PWM

0

4.3O±L86

369.88±76.57

28.98±13.23

20

1.80±0.81a

228.33±133.25

100

1.82±O.89a

500

1.41±O.52a

ConA

PHA

707.93±170.38

141.62± 2.92

9.76± 5.75 a

268.67±234.72

59.01±42.67

182.70± 52.44a

7.79± 3.87 R

143.43±l09.34a

43.31±22.48

170.33± 67.67 a

7.34± 1.37a

179.04±l05.21 a

39. 97±24.05a

b

'" Toluene was administered continuously to CD-l mice in drinking water for 4 weeks.
•• dpm/2xl06 splenic cells (xlO-3): response evaluated by incorporation of [methyl- 3
thymidine into
day 2 splenocyte cultures for 6 hours pulsing. Values are given as mean ± S.D. (n = 5).

a] -

a Significantly (p < 0.05) different from control (0 mg/L) values.

TABLE 21. Effect of Toluene Exposure on Mixed Lymphocyte Response.
DPM/106 cells (xlO- 3)**
Dose*
(mg/L)

Responders

Responders + Stimulators

0

5.20±0.67

28.99± 9.30

20

4.62±O.92

29.18±11.26

100

4.72±2.20

23.30± 7.80

500

2.47±O.42a

14.87± 4.79a

* * Responder cells were the syngeneic splenic cells of CD-I mice and stimulator cells were the allogeneic
Yac-! ceUs. A ratio of two stimulators to one responder was used, and the stimulator cells were treated
with mitomycin-C before addition to the culture. MLC evaluated by incorporation of [methyl-3H] thymidine into day 3 MLC cultures for 6 hours pulsing. Values are given as mean ± S.D. (n = 5).
* Toluene was administered continuously to CD-l mice in drinking water for 4 weeks.
a Significantly (p < 0.05) different from control (0 mg/L) values.
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TABLE 22. Effect of Toluene Exposure on Cytotoxic T-Lympbocytes (en.) Response.
%Cytotoxicitya
Dose
(mgIL)

50:1 b

25:1

0

13.74±1.47b

16.49±7.45

20

12.09±O.75

13.29±2.47

100

11. 19±O.82

12.34±1.31

500

10.30±1.40

8.67±1.60*

a Values are given as mean ± S.D. (n = 5).
b Effector-to-target cell ratio.
'" Significantly (p < 0.05) different from control (0 mgIL) values.

TABLE 23. Effect of Toluene Exposure on Antibody Plaque Forming Cells (PFC) and Antibody Titer (a.SRBC)'"

Dose**
(mg/kg/day)

Total Splenocytes
(dO·7 )

PFC/106

PFCrrotal

Splenocytes

Spleen Cells

a.-SRBC
Antibody Titer

0

20. 16±2.75

1,184± 90

238,545±37,429

0.44±0.04

5

16.68±1.19

985±105

166,015±30,231

0.55±0.06

22

21.78±3.05

973±116

217,891±47,845

0.43±O.05

105

13.66±1.79

631£278

89,936±13,26~

0.32±O.03

'" Mice were sensitized with thymic-dependent antigen sheep erythrocyte (SRBC) four days before the end
of toluene exposure. Splenocytes were analyzed for antibody plague forming cell and antibody titer (a.SRBC) determined in Sera. Values are given as mean ± S.E. (n =5).
"'* Toluene was administered continuously to CD-I mice in drinking water for four weeks.
a Significantly (p < 0.05) different from control (0 mgIL) values.
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TABLE 24. Effect of Toluene On Regional Brain Catecholamines
Brain Regiona

Catecbolamineb

NE

VMA

Dosec
(mg/L)

Hypothalamus

Medulla
Oblongata

Cerebellum

SOO
100
20
0

1.76±0.30*
2.13±0.37*
1.98±0.OS*
1.31±0.lS

0.78±0.07
0.9S±0.21*
0.70±0.10
0.66±0.O6

0.38±0.O4
0.42±0.OS
0.34±0.03
0.33±0.09

SOO
100
20
0

0.60±0.47
0.39±O.10
0.42±0.O3
0.24±O.04

O.30±0.04
0.36±0.09*
0.30±0.03
O.2S±O.01

0.24±0.02
O.27±0.04
0.29±O.02
0.2S±O.03

SOO
100
20
0

O.13±O.OS
0.23±0.OS*
0.18±0.03*
0.09±0.O2

0.03±0.01
0.07±0.02*
0.04±O.01
0.04±0.02

0.O3±0.01
0.O3±0.01
0.02±0.00
O.03±O.01

SOO
100
20
0

0.68±0.21*
0.74±0.19*
0.66±0.14*
0.40±0.10

0.10±0.02
0.10±0.04
0.07±0.03
0.10±0.01

O.OS±O.Ol
0.04±O.02
0.04±0.01
0.04±0.01

SOO
100
20
0

0.U±O.16
0.22±O.06
0.09±0.13
O.ll±O.l1

0.03±0.04
O.l0±0.OS
0.03±O.O2
0.06±O.O2

O.02±0.02*
O.O4±O.01
O.O1±0.02
0.01±0.02

)

DOPAC

DA

HVA

a I.tg: brain biogenic amines/g wet brain tissue (means ± S.D., n = S).

b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxyphenylacetic acid, DA:
dopamine, HVA: homovanillic acid.
C Doses were administered continously to CD-l mice in drinking water for 4 weeks.
* Significantly (p < O.OS) different from control (0 mg/L) values.
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TABLE 2S. Effect of Benzene on Regional Brain Catecholamines

Brain Regiona

Catecholamineb

NE

VMA

DOPAC

DA

HVA

Dosec
(mg/L)

Midbrain

Cotpus
Striatum

Cortex

SOO
100
20
0

0.69±O.04*
0.67±o.06*
0.66±O.07*
0.S8±O.03

0.36±0.11
0.3S±0.03
0.37±0.09
0.32±0.10

0.43±0.OS
0.46±0.06
0.41±0.06
0.36±0.04

SOO
100
20
0

0.38±O.02*
0.36±o.03*
0.32±O.02
0.30±O.OS

0.S7±0.07*
0.41±O.04*
0.32±0.04
0.3l±O.02

0.3S±0.01*
0.2S±O.03
0.27±O.01
0.2S±0.04

SOO
100
20
0

0.12±O.O2
0.13±O.O4
0.19±O.1l
0.14±O.02

1.39±0.17
1.06±0.12
1.06±0.47
1.06±0.46

0.18±0.03
0.19±0.03
0.16±0.04
0.19±O.02

SOO
100
20
0

0.39±O.14
0.3l±O.09
0.78±O.68
0.27±O.06

11.6S±1.1l*
8.28±1.07*
7.34±2.09
6.41±O.76

1.13±O.19
1.24±O.36
1.12±0.29
1. 20±0. 2 1

SOO
100
20
0

0.13±O.02
0.12±O.02
0.16±O.07
0.13±O.OS

1.24±O.17*
0.9S±0.14
0.79±0.3S
0.83±0.20

0.17±0.04
0.18±0.OS
0.14±O.03
0.18±0.04

a J.1g: brain biogenic amines/g wet brain tissue (mean ± S.D., n

=S).

b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxyphenylacetic acid, DA:

dopamine, HVA: homovanillic acid.
C

Doxes were administered continuously to CD-I mice in drinking water for 4 weeks.

* Significantly (p < O.OS) different from control (0 mg/L) values.
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TABLE 26. Effect of Toluene on Regional Brain Indoleamines.
Brain Regiona
Dosesc
(mgIL)

Hypothalamus

5·HT

500
100
20
0

5·1DAA

500
100
20
0

Indoleamineb

Medulla
Oblongata

Cerebellum

1.00±0.26
1.44±O.43*
0.94±O.20
0.70±0.16

0.90±0.10*
1.07±0.15*
0.79±0.07
0.76±O.05

0.19±0.06
0.27±O.06
0.19±0.06
0.22±0.12

0.49±0.17
0.86±O.28*
0.65±0.15
0.37±0.07

0.31±0.07
0.43±O.IO*
0.33±0.04
0.32±0.03

0.06±0.01
0.11±0.04
0.08±0.03
0.09±0.05

a p,g: brain biogenic amioes/g wet brain tissue (mean ± S.D., n ::.. 5).

b 5-HT: 5-hydroxytryptamine (serotonin), 5·1DAA: 5-hydroxyindoleacetic acid.
Doses were administered continuously to CD-I mice in drinking water daily for 4 weeks.
* Significantly (p < 0.05) different from control (0 mgIL) values.

C

TABLE 27. Effect of Toluene on Regional Brain Indoleamines
Brain Regiona

Indoleamineb

5-HT

5-1DAA

Dosesc
(mgIL)

Midbrain

Corpus
Striatum

Cortex

500
100
20
0

0.9S±O.04*
1.10±O.16*
1.02±1.10*
0.76±O.04

O.72±O.OS*
0.76±0.09*
0.64±0.11
0.53±0.OS

0.65±0.01*
0.79±0.11 *
0.66±O.02*
0.53±0.03

500
100
20
0

0.32±O.02
0.42±O.14
0.42±O.05
0.37±O.01

0.40±0.07
0.42±OJ}3
0.39±0.OS
0.35±0.06

0.lS±0.02
0.23±0.06*
0.19±0.03
0.17±0.02

a p,g: brain biogenic amines/g wet brain tissue (mean ± S.D., n ::.. 5).
b 5-HT: 5-hydroxytryptamine (serotonin), 5-1DAA: 5-hydroxyindoleacetic acid.
c Doses were administered in drinking water daily for 4 weeks.
* Significantly (p < 0.05) different from control (0 mgIL) values.
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TABLE 28. Effect of Phenol Exposure on Body Weight Gain in CD-l Mice.

Concentration in water, mg/La

Nominal

Body Weight Gain
(gm)b

Dose
(mg/kwday)

Observed

0

0

5

4.75

20

19.0

5.35

9.78 ± 2.03

100

95.0

26.55

10.92 ± 1.84

9.58 ± 1.04

0
(Control)
1.36

10.26 ± 1.46

a The observed concentrations for phenol were approximately 95 percent of the nominal concentrations.

bValues are given as mean ± S.D. (n:= 5).

TABLE 29. Organ and Body Weight of CD-1 Mice Following Phenol Exposure.

Organ Weight Relative to Body Weight (gm/lOOgm)b
Dosea
(mg/L)

BodyWeigbt
(gm)

Spleen

Uver

Kidney

Thymus

0

33.66±1.23

0.35±O.04

6.48±O.59

1.56±O.20

0.15±0.Ol

5

33.54±1.57

0.32±O.07

6.25±O.44

1.76±O.11

0.14±O.04

20

33.68±1.73

0.33±0.04

6.lO±O.79

1.68±O.19

0.14±O.03

100

34.86±2.20

0.29±O.03

6.01±0.07

1.71±O.25

0.12#>.02

a Phenol was administered continuously to CD-1 mice in drinking water for four weeks.

bvalues are given as mean ± S.D. (0 = 5).
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TABLE 30. Effect of Phenol Exposure on Spleen Cellularity and Selected Blood Parametersa .

Doseb Total spleen
(mgIL) Cellularity
(xl 0-7 )

C

WBC
(xlO- 3)

C

RBC
(xlO- 3)

PCV

d

Expressed as % ofWBC's

%
Lymphocytes Neutrophils

Monocytes

0

8.59±0.75

6.06±0.38

7. 17±1.24

48.00±1.17

74.20±4.09

17.0o±2.24

4.60±1.14

5

7.94±0.44

5.82±1.34

4.90±1.20* 49.10±1.52

71.80±4.60

19.4o±1.67

4.80±2.28

20

7.31±0.90

5.05±1.19

4.64±1.69* 48.20±2.77

69.2o±7.26

21.8o±5.36

4.60±1.82

lOO

7.26±1.23

5.68±1.54

3.23±1.51 * 44.1o±1.82*

73.6o±5.18

17.0o±3.46

6.20±2.59

8Values are given as mean ± S.D. (n = 5).
bphenol was administered continuously to CD-1 mice in drinking water for four weeks.
cCell/cu mm.
dpacked cell volume
*Significantly (p<0.05) different from control (0 mgIL) values

TABLE 31. Effect of Phenol Exposure on the Uptake of [3H ]-thymidine by Mice Spleen Cells
in Culture.

Dosea
(mgIL)

Unstimulated
Cultures

LPS

PWM

o

5.98±2.18

166.26±53.74

23.59±1O.44

174.33±120.17

146.16 ± 76.44

5

5.4o±1.80

173.08±53.92

22.00 ± 6.06

118.94± 91.72

150.66±100.72

20

5.62±2.48

148.78±78.82

16.06 ± 8.94

79.00 ± 46.10

106.60 ± 31.34

100

3.13±O.80*

89.74±61.58*

8.16 ± 2.99*

Con A

PHA

95.39 ± 35.96

~henol was administered continuously to CD-I mice in drinking water for four weeks.
bValues are given as mean ± S.D. (n=5).
*Significant (p<0.05) difference from control (0 mg/L) values
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62.25 ± 42.28*

TABLE 32. Effect of Phenol Exposure on Mixed Lymphocyte Response.

Dose'"
(mg/L)

Responders

Responders + Stimulators

o

7.02±1.96a

22.04±6.71

5

4.68±2.29

24.87±5.26

20

3.99±2.89

10.6S±0.84a

100

4.16±1.01

'" Phenol was administered continuously to CD-I mice in drinking water for four weeks.

*'" Responder ceUs were the syngeneic splenic cells of CD-I mice and stimuJator cells were the aUogeneic
Yac-I cells. A ratio of two stimulators to one responder was used, and the stimulator cens were treated
with mitomycin-C before addition to the cuJture. MLC evaluated by incorporation of [methyl-3H]thymidine into day 3 MLC cultures for 6 hours pulsing. Values are given as mean ± S. D. (n=5)

a Significant (p<0.05) difference from control (0 mg/L) values

TABLE 33. Effect of Phenol Exposure on Cell-Mediated Cytolytic Response.

% Cytoxiclt~

Dose
(mg/L)

25:1

o

12.59±1.04

13.84±0.75

5

12.03±2.55

12.3o±2.30

20

11.80±1.67

12.20±2.94

100

10.99±1.74

11.23±2.45

"values are given as mean ± S.D. (n=5)
aEffector-target cen ratio
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TABLE 34. Effect of Phenol Exposure on Antibody Plaque Fonning Cells (PFC) and
Antibody Titer (a.-SRBC)a.

Doseb

6

PFC/10 Splenic Cells

PFCrrotal Splenic Cells

(mg/L)

a.-SRBC
Antibody Titer

o

1,123±221

265,947±118,731

0.446±o.086

5

896±135

241,678± 39,129

0.392±o.152

20

795±110*

207,659± 42,184

0.325±0.042*

100

616±186*

130,185± 40,699*

0.263±0.082*

&Values are given as mean ± S.D. (n=5)
bphenol was administered continuously to CD-I mice in drinking water for four weeks.
*Significantly (p<O.05) different from control (0 mg/L) values.
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TABLE 35. Effect of Phenol on Regional Brain Catecbolamines.
Brain Regions8
Catecholamineb

Dosec
(mg/L)

Hypothalamus

Medulla Oblangata

Cerebellum

NE

100
20
5
0

1.272±O.416'"
1.470±0.403'"
1.878±O.166
2.089±0.282

0.599±O.089
0.628±O.085
0.681±O.065
0.767±O.147

0.287±O.021
0.325±O.033
0.348±O.066
0.376±O.066

VMA

100
20
5
0

0.351±0.117
0.402±0.058
0.420±0.065
0.492±0.067

0.305±O.029
0.324±O.047
0.366±O.053
0.400±O.074

0.330±O.018
0.384±O.051
0.382±O.038
0.377±O.052

DOPAC

100
20
5
0

0.216±0.081
0.255±0.042
0.268±0.066
0.310±0.079

0.079±O.007
0.094±O.027
0.085±O.019
0.081±O.01O

0.047±O.006'"
0.058±O.008
0.057±O.007
0.057±O.003

DA

100
20
5
0

0.412±0.158
0.490±0.154
0.523±O.I24
0.569±0.098

0.042±O.020
0.037±O.013
0.045±O.015
0.047±O.006

0.020±0.006
0.024±O.003
0.027±O.006
0.032±O.015

a J.lg: Brain biogenic amines/g wet brain tissue (mean ± S.D., n=5). Amounts of HVA were not

detecred.

.

b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dihydroxypbenylacetic acid" DA:

dopamine.
C Doses were administered continuously to CD-I mice in drinking water for 4 weeks.
'" Significantly (p<O.05) different from control (0 ppm) values.
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TABLE 36. Effect of Phenol on Regional Brain Catecholarnines.
Brain Regionsa
Dosec
(mg/L)

Midbrain

Corpus Striatum

Cortex

NE

100
20
5
0

0.560±0.025
0.570±0.094
0.656±0.058
0.608±0.093

0.308±O.068
0.379±O.045
0.414±O.088
0.379±O.127

0.405±O.029
0.370±0.068
0.473±O.142
0.424±O.O31

VMA

100
20
5
0

0.318±0.011 *
0.352±0.042
0.379±0.028
0.402±0.050

0.298±O.030*
O.383±O.056
0.414±O.034
0.398±O.O32

0.326±0.022*
O.329±O.028*
0.371±O.012
0.372±O.O07

DOPAC

100
20
5
0

0.161±0.024
0.174±O.012
0.209±O.058
0.219±O.040

0.947±O.153*
1.1 48±O.377
1.OOO±O.J 53
1.326±O.203

0.221±O.008
0.239±O.023
0.277±O.059
0.261±O.018

DA

100
20
5
0

0.275±O.061
0.275±0.046
0.463±0.205
0.320±0.092

6.529±O.950*
7.257±O.849*
7.749±1.166*
9.797±1.887

1. 173±O.180
1.310±0.1l5
1.685±O.405
1.517±O.317

HVA

100
20
5
0

0.105±0.013
0.109±0.009
0.131±O.038
0.136±O.022

0.774±O.J46
0.805±O.049
O.752±O.128
0.952±O.142

0.176±O.015
0.173±O.017
0.201±O.060
0.214±O.029

Catecholarnineb

a

I1g: Brain biogenic ammes/g wet brain tissue (mean ± S.D., n=5).

b NE: norepinephrine, VMA: Vanillylmandelic acid, DOPAC: dibydroxyphenylacetic acid, DA:

dopamine, HVA: homovanillic acid
Doses were administered continuously to CD-I mice in drinking water for four weeks.
* Significant (p<O.05) difference from control (0 mg/L) values.

C
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TABLE 37. Effect of Phenol on Regional Brain Indoleamines.
Brain Regionsa
Dosec
(mg/L)

Hypothalamus

Medulla Oblangata

Cerebellum

5-Hf

100
20
5
0

0.422±0.119'"
0.656±0.236'"
0.S59±O.114
0.967±O.OS7

0.531±O.079'"
0.613±O.105
0.705±O.045
0.752±O.163

OJ 61±O.050
0.193±O.035
0.207±O.063
0.243±O.06S

5-HIAA

100
20
5
0

0.237±O.061'"
0.342±O.10S'"
0.476±O.OSI
0.502±O.097

0.207±O.031
0.247±O.024
0.258±O.026
0.272±O.057

0.067±O.021
0.073±O.013
0.081±O.021
0.088±O.026

Indoleamineb

a Jig: Brain biogenic amines/g wet brain tissue (mean ± S.D., n=5).
b 5-Hf: 5-hydroxytryptamine (serotonin), 5-HIAA: 5-hydroxyindoleacetic acid.

Doses were administered continuously to CD-I mice in drinking water for four weeks.
'" Significantly (p<0.05) different from control (0 mg/L) values.
C

TABLE 38. Effect of Phenol on Regional Brain Indoleamines.
Brain Regionsa
Dosec
(mg/L)

Midbrain

Corpus Striatum

Cortex

5-Hf

100
20
5
0

0.722±O.059'"
0.824±0.154
0.994±0.OS5
0.890±0.037

0.457±o.054'"
0.627±o.082
0.735±o.140
0.669±o.052

0.591±O.050
0.611±o.052
0.797±o.186
0.707±o.039

5-HIAA

100
20
5
0

0.320±0.060
0.332±0.069
0.411±0.055
0.384±o.023

0.257±o.036
0.358±o.045
0.390±o.097
0.344±o.066

0.185±o.020
0.167±O;015
0.213±o.067
0.197±o.()16

Indoleamineb

a Jig: Brain biogenic amines/g wet brain tissue (mean ± S.D., 0=5).

hydroxytryptamine (serotonin, 5-ffiAA: 5-hydroxyindoleacetic acid.
Doses were administered continuously to CD-I mice in drinking water for four weeks
'" Significantly (p<0.05) different from control (0 mg/L) values.

b 5.HT:
C
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TABLE 39. Body Weigbts of Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and Toluene
(400 mg/L). alone or Combined.
Body Weight (g)a
Concentration
in Water (mg/L)

Day 0

Day 28

Gain

Control (0)

27.02 ± 0.73

34.36 ± 0.78

7.34 ± 0.27

Benrene (200)

27.02 ± 0.56

35.70 ± 1.01

8.68 ± 0.61

Toluene (400)

27.46 ± 0.48

37.32 ± 1.34

9.86 ± 0.90b

26.78 ± 0.37

34.22 ± 0.39

7.44 ±0.43c

Benrene (200)

+
Toluene (400)

a Values are given as mean ± S.E. (n=5)
b Significantly different from untreated controls (p<O.05)
c Significantly different from toluene treaunent alone (p<0.05)

TABLE 40. Organ Weigbts of Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and Toluene
(400 mg/L), alone or Combined.
Organ Weights (g/lOOg body weight)a
Concentration
in Water (mg/L)

Spleen

Kidney

Liver

Thymus

Control (0)

0.31 ± 0.01

1.46 ± 0.05

5.77 ± 0.16

0.14 ± 0.01

Benrene (200)

0.28 ± 0.02

1.59 ± 0.08

6.28 ± 0.17

0.09 ± 0.02b

Toluene (400)

0.29 ± 0.02

1.54 ± 0.04

5.92 ± 0.17

0.11 ± 0.01

0.28 ± 0.01

1.56 ± 0.05

5.77 ± 0.16

0.11 ± 0.01

Benzene (200)

+
Toluene (400)

a Values are given as mean ± S.E. (n=5)
b Significantly different from untreated controls (p<O.05)
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TABLE 41. Effect of Exposure to Benzene (200 mgIL) and Toluene (400 mgIL), Alone or Combined, on Selected Blood Parametersa.
uukocyte absolute differentia1s (103Jmm3)
Concentration
(mgIL)

U'I
U'I

(l06/mm 3)

uuk.ocyte
(l03/mm 3)

Control (0)

9.73 ± 0.18

6.90 ± 1.08

5.19 ± 1.03

Benzene (200)

7.09 ± 0.2Sc

4.44 ± 0.1~

2.43

Toluene (400)

9.78

4.67

Etytbrocyte

± 0.23

6.46

± 0.61

Lymphocyte

Neutrophil

Otherb

1.17 ± 0.11

0.54± 0.09

± 0.1~

1.60 ± O.11c

0.31

± 0.54

1.24 ± 0.05

0.55 ± 0.08

3.60 ± 0.31c,d

1.57 ± 0.16c

0.44 ± 0.07

± 0.04

Benzene (200)

+
Toluene (400)

9.45 ± 0.38 d

5.62 ± 0.35

a Values are given as mean ± S.E. (n=5).
b Including monocytes, eosinophils and basophils.
c Significantly different from untreated controls (p<O.05).
d Significantly different from benzene treatment alone (p<O.OS).

f'

If

fff

TABLE 42. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L). Alone or Combined, on Splenic Lymphocyte Proliferative Response to
Mitogens.
.
Mitogenic responsesa,b

VI

Concentration
(mg/L)

Splenocytesa
(xl 0-7)

None

LPS

PWM

Control (0)

8.94 ± 1.90

2.02 ± 0.48

79.36 ± 20.14

8.99 ± 0.43

Benzene (200)

7.90 ± 1.67

1.07 ±0.29

15.01 ± 3.22c

2.53 ± 0.83c

13.79 ± 3.48c

14.18 ± 2.15c

Toluene (400)

8.61 ± 1.16

1.59 ± 0.52

32.14 ± 5.24

7.72 ± 2.11

34.87 ± 7.37

43.53 ± 13.S5

9.29 ± 0.75

3.17 ± 0.S9d ,e

10.66 ± 1.31 d

174.51 ± 93.59d

ConA
85.45 ± 39.75

PHA

103.40 ± 34.64

0\

Benzene (200)

+
Toluene (400)

12S.41 ± 23.93 d,e

a Values are given as mean ± S.B. (n=5).
b dpm x 10-3/106 splenic cells: response evaluated by incOlporation of [methyl-3H]-thymidine.
into day 2 splenocyte cultures for 6 hours pulsing.
c Significantly different from untreated controls (p.0.05).
d Significantly different from benzene treatment alone (p.O.OS).
e Significantly different from toluene treatment alone (p.0.05).

~
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119.S7 ± 2.50d

TABLE 43. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L). Alone or Combined.
on Mixed Lymphocyte Response.
Responder-to-stimulator cell mtioa
Concentration
(mg/L)

Responders alone

1:1

2:1

4:1

17.69 ± 2.70

17.25 ± 2.59

Control (0)

1.91 ± 0.36

6.58 ± 0.88

Benzene (200)

0.88 ± 0.22b

4.03 ± 0.53

5.69 ± l.64b

6.50 ± 1.17b

Toluene (400)

1.09 ± 0.14

3.93 ± 0.60

8.67 ± 2.24b

9.00 ± 0.95 b

1.99 ± 0.33c ,d

7.80

Benzene (200)

+
Toluene (400)

± 2.46

22.85 ± 4.62c ,d

21.84 ± 3.83c •d

a Responder cells were the splenocytes of CD-I mice and stimulator cells were the allogeneic YAC-I
lymphoma cells (H_2a) of AISn origin. The stimulator cells were treated with mytomycin-C before

addition to the culture. MLR was evaluated by incorporation (dpm x 10-3) of [methyl-3H]-thymidine
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ± S.E. (n=5).
b Significantly different from untreated controls (p<O.05).
c Significantly different from benzene treatment alone (p<0.05).
d Significantly different from toluene treatment alone (p<0.05).
TABLE 44. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined. on
Cytotoxic T- Lymphocyte Response.
% Cytotoxicitya

Concentration
(mg/L)

50:1b

25:1

12.5:1
13.23 ± 1.65

Control (0)

18.74 ± 1.79

18.66 ± 1.39

Benzene (200)

13.29 ± 1.07

14.43 ± 3.78

Toluene (400)

17.33 ± 1.85

16.85 ± 2.39

24.11 ± 1.83c ,d,e

23.74

7.20 ± 0.81c
,9.43 ± 0.71

6.25:1
7.88 ± 1.66
4.67 ± 0.59
6.34 ± 0.86

Benzene (200)

+
Toluene (400)

± 1.06d,e

18.11

± 2.69d,e

9.83

± 1.02d

a Values are given as mean ± S.E. (n=5).
bEffector (day 5 mixed lymphocyte culture lymphocytes)-to-target (51 Cr-Iabeled YAC-l ceUs) cell ratio.
c Significantly different from untreated controls (p<O.05).
d Significantly different from benzene treatment alone (p<0.05).
e Significantly different from toluene treatment alone (p<O.05).
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TABLE 45. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on
Antibody Responses to T-Dependent Antigen Sheep Erythrocyte (SRBC)8.

Concentration
(mg/L)

Total
splenocytes
(x 10-7)

Control (0)

22.01 ± 2.29

Benzene (200)

17.81 ± 1.18

Toluene (400)

PFC/I06
splenocytes

PFC/total spleen cells
(x 10-3)

a. -SRBC
antibody titer

337.36 ± 44.82

0.78 ± 0.07

833 ± 89b

151.41 ± 21.53b

0.47 ± 0.05b

19.02 ± 1.03

1190 ± l09b

229.51 ± 32.30

0.37 ± 0.03

22.93 ± 1.61

1972 ± 159b •c ,d

454.90 ± 42.48c •d

1.24 ± O.lOb •c ,d

1485 ± 66

Bemene (200)

+
Toluene (400)

8 Mice were sensitized with SRBC 4 days before the end of exposure. Splenic cells were analyzed for
antibody fonning cells (plaque-fonning cell, PFC) and antibody titer (a. -SRBC) detennined in Sera.
Values are given as mean ± S.E. (n=5).
b Significandy different from untreated controls (p<O.05).
C Significantly different from benzene treatment alone (p<0.05).
d Significantly different from toluene treatment alone (p<0.05).

TABLE 46. Body Weights of CD- t Mice Following 4 Weeks of Exposure to Benzene (200 mg/L) and
Toluene (100 mg/L), Alone or Combined.
Body Weight (g)a
Concentration
in Water (mg/L)

Day 0

Day 28

Gain

Control (0)

23.38 ± 0.79

31.12 ± 1.02

7.73 ± 0.41

Benzene (200)

22.50 ± 0.72

. 30.44 ± 0.75

7.94 ± 0.54

Toluene (100)

25.38 ± 0.75

34.72 ± 1.20

9.34 ± 0.56

25.42 ± 0.75

34.14 ± 1.25

8.72 ±0.84

Bemene (200)

+

Toluene (100)
a Values

are given as mean ± S.E. (n=5).
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TABLE 47. Organ Weights of Mice Following 4 Weeks Exposure to Benzene (200 mg/L) and Toluene
(100 mg/L), Alone or Combined.

Organ Weights (gll00g body weigbt)a
Concentration
in Water (mg/L)

Kidney

Spleen

Tbymus

liver

Control (0)

0.29

± 0.01

1.79

± 0.10

6.19

± 0.13

0.17

± 0.01

Benzene (200)

0.24

± 0.92

1.73

± 0.11

6.29

± 0.23

0.14

± O.Olb

Toluene (100)

0.29

± 0.03

1.74 ± 0.05

6.02

± 0.17

0.15

± 0.01

0.26

± 0.01

1.73

± 0.08

6.38

± 0.17

0.14 ± O.Olb

Benzene (200)

+
Toluene (100)

a Values are given as mean ± S.E. (n=5).
b Significantly different from untreated controls (p<f>.05).

TABLE 48. Effect of Exposure to Benzene (200 mg/L) and Toluene (l00 mg/L), Alone or Combined. on
Splenocyte and Erythrocyte Cellularities.
Erytbrocytea
(106/mm 3)

Concentration
(mg/L)

Splenocytea
(xl0~7)

Control (0)

10.80

± 1.14

9.36

± 0.18

Benzene (200)

7.8

± 0.05

6.77

± 0.35 b

Toluene (100)

11.38

± 1.87

10.42

± 0.34 .

Benzene (200)

+
Toiuene (100)

10.74 ± 0.70

a Values are given as mean ± S.E. (n=5).
b Significantly different from untreated controls (p<O.05).
C Significantly different from benzene treatment alone (p<O.05).
d Significantly different from toluene treatment alone (p<0.05).
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TABLE 49. Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L). Alone or Combined,
on Splenic Lympbocyte Proliferative Response to Mitogens.
Mitogenic responsesB
Concentration
(mg/L)

0\

0

None

LPS

Control (0)

2.10 ± 0.71

55.52 ± 10.24

Benzene (200)

0.52 ± 0.23

4.07 ± 1.10b

Toluene (100)

1.49 ± 0.28

27.13

± 9.92

PWM

ConA

PHA

± 1.83

72.03

± 13.33

NOC

3.31 ± 1.32

10.55

± 2.82b

NO

4.49 ± 0.53

35.72 ± 8.77

3.79 ± 1.06

23.55

6.72

NO

Benzene (200)

+
Toluene (100)

2.05 ± 0.72

6.02 ± 1.68b

dpm x 10-3/106 splenic cells: response evaluated by incotporation of [metbyl.3H]-tbymidine into day 2
splenocyte cultures for 6 bours pulsing. Values are given as mean ± S.B. (n=5).
b Significandy different from untreated controls (p<O.05).
C NO, not determined.

B
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± 2.82b

NO

TABLE 50.

Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L), Alone or Combined, on
Mixed Lymphocyte Responses.
Responder-to-stimulator cell mtioR

Concentration
(mglL)

Responders Alone

1:1

2:1

4:1

Control (0)

2.13 ± 0.59

7.98 ± 1.84

18.73 ± 2.16

16.47 ± 0.89

Benzene (200)

1.00 ± 0.13

7.05 ± 1.49

Toluene (100)

1.43 ± 0.63

6.29 ± 0.64

1.54 ± 0.37

7.36 ± 1.36

8.62 ± 1.60b
14.25 ± 1.51

5.76 ± 0.69b
11.29 ± 3.37

Benzene (200)

+
Toluene (100)

8.54 ± 1.16b ,c

8.16 ± 1.60b

RResponder cells were the splenocytes of CD-I mice and stimulator cells were the allogeneic YAC-l
lymphoma cells (H_2R) of AlSn origin. The stimulator cells were treated with mytomycin-C before
addition to the culture. MLR was evaluated by incorporation (dpm x 10-3) of [methyl-3H]-thymidine
into day 3 MLR cultures for 6 hours pulsing. Values are given as mean ± S.E. (n=5).
b Significantly different from untreated controls (p<O.05).
c Significantly different from toluene treatment alone (p<0.05).

TABLE 51.

Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on
Bmin Biogenic Amines and Their Major Metabolites in Hypothalamus.
.
Concentrations (J.lg/g Wet Tissue)R

Doses
(mgIL)

NE

DA

Control (0)

1.87±O.14

0.49±0.08

Benzene (200)

2.77±O.26b

Toluene (400)

5-RT

DOPAC

HVA

5-HlAA

0.37±O.05

0.22±0.04

0.16±O.02

0.32±0.07

0.74±O.07b

0.71±O.04b

0.37±O.07

0.26±O.03b

0.69±O.04b

2.90±0.18b

0.62±O.O7

0.76±O.07b

0.35±O.05

0.24±O.03

0.68±0.05b

3. 19±O.30b

0.82±O.06b

0.71±O.08b

0.42±0.05

0.29±O.03 b

0.76±0.06b

Benzene (200)

+
Toluene (400)

RValues are given as mean ± S.E. (n=5).
b Significantly different from untreated controls (p<0.05).
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TABLE 53. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on Brain Biogenic Amines and Their
Major Metabolites in Corpus Striatum and Midbrain of CD-I Mice.
Biogenic Amines Concentrations (Ilg/g Wet Tissue)a
Brain
Region

Corpus
Striatum

Doses
(mg/L)

NE

Control (0)

0.3I±O.06

Bell2"ene (200)
Toluene (400)

DA

S-HI'

VMA

DOPAC

HVA

S-HIAA

7.27±O.SS

0.36±O.OS

0.12±O.02

1.21±0.07

0.93±0.07

0.SS±O.07

0.43±O.06

10.10±0.62b

O.64±O.OSb

0.16±0.01

1.43±0.11

1.28±O.09b

0.67±O.06

0.44±O.07

9.01±O.48

0.6I±O.09b

O.13±O.OI

1.46±O.13

1.09±0.OS

0.58±O.OS

Toluene (400)

0.4S±O.03

9.2S±O.S~

0.60±0.03b

O.l1±O.OI

1.92±0.16b,c,d

1.27±O.OSb

0.72±O.04

Control (0)

0.66±O.03

0.27±O.OS

0.68±0.03

0.09±0.02

0.21±0.03

0.13±0.01

O.5S±O.01

Bell2"ene (200)

0.84±O.03b

0.39±O.04

1. I O±O. 02b

0.08±0.00

0.18±O.01

0.19±O.0Ib

0.71±O.04b

Toluene (400)

0.73±O.02

0.44±O.18

0.9S±O.04b

0.10±0.01

0.22±O.04

0.18±O.02

0.63±O.03

0.67±O.OSc

0.38±0.04

O.89±O.09

O.13±O.OIb,c

0.18±O.01

0.16±0.01

0.71±O.03b

Bell2"eDe (200)

+
0\

1...:1

Midbrain

Bell2"ene (200)

+
Toluene (400)

a Values are given as mean ± S.E. (n=5).
b Significantly different from coJ;ltrois (p<O.05).
C Significantly different fum benzene treabnent alone (p<O.05).
d Significantly different from toluene treatment alone (p<O.05).

TABLE 54. Effect of Exposure to Benzene (200 mg/L) and Toluene (400 mg/L), Alone or Combined, on
Brain Biogeoic Amines and Their Major Metabolites in Cerebellum of CD-I Mice.

Concentrations (Ilg/g Wet Tissue)a
Doses
(mg/L)

NE

5-HT

VMA

5-HIAA

Control (0)

0.24

± 0.02

0.12

± 0.02

0.12

± 0.02

0.17

± 0.01

Benzene (200)

0.30

± 0.01

0.19

± 0.01

0.10

± 0.02

0.17

± 0.00

Toluene (400)

0.31

± 0.02

0.13

± 0.02

0.14

± 0.05

0.16

± 0.02

0.34

± O.03 b

0.16

± 0.01

0.15

± 0.03

0.18

± 0.01

Bem.ene (200)

+
Toluene (400)

a Values are given as mean ± S.E. (n=5).
b Significantly different from controls (p<O.05).

a Values are given as mean ± S.E. (n=5).
b Significantly different from controls (p<0.05).
C Significantly different from benzene treatment alone (p<O.05).
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TABLE 57. Effect of Exposure to Benzene (200 mgIL) and Toluene (100 mgIL), Alone or Combined, on Brain Biogenic Amines and Their Major Metabolites in
Corpus Striatum and Midbrain of CD-I Mice.
Biogenic Amines Concentrations (Ilg!g Wet Ttssue)a
Braio
Region

Corpus
Striatum

<.:1'1
<.:1'1

Doses
(mgIL)

NE

DA

5-Hr

OOPAC

HVA

5-FHAA

Control (0)

0.33±O.04b

7.14±O.63

0.64±0.04

0.S2±O.OS

O.S7±O.11

O.41±O.04

BeJl7ale (200)

O.43±O.04

S.6S±O.21

0.67±0.O5

1.07±O.05

1.21±O.04b

O.49±O.O6

Toluene (100)

0.54±O.04b

S.02±O.46

O.67±0.O6

1.16±O.06b

1.2S±O.04b

O.54±O.05

Benzene (200)
+
Toluene (100)

O.54±0.05b

9.23±O.36b

O.77±O.OS

1.25±O.lOb

1.51±0.07b,c.d

O.56±O.OS

Control (0)

O.55±O.O5

O.19±O.OI

O.SO±O.09

O.13±O.OI

O.16±O.O2

O.49±O.O2

Benmne (200)

O.74±O.02b

O.33±O.OS

1. 13±O.04b

O.13±O.OI

O.l9±O.Ol

O.66±O.04b

Toluene

(100)

O.66±0.04

O.22±0.O2

O.96±O.07

O.ll±O.02

O.15±O.Ol

0.67±O.OSb

Benmne (200)
+
Toluene (100)

O.65±0.04

0.34±O.07

O.97±O.07

O.17±O.03

0.22±0.03

0.67±O.OSb

Midbrain

Values are given as mean ± S.E. (n=5).
b Significantly different from controls (p<O.05).
c Significantly different from benzene treatment alone (p<O.05).
d Significantly different from toluene treatment alone (p<O.05).
a
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TABLE 58.

Effect of Exposure to Benzene (200 mg/L) and Toluene (100 mg/L), Alone or Combined, on
Brain Biogenic Amines and Their Major Metabolites in Cerebellum of CD-I Mice.

Concentrations (J.lg/g Wet Tissue)a

Doses
(mg/L)

5-HT

NE

5-lflAA

Control (0)

0.24

± 0.03

0.14

± 0.03

0.14

± 0.02

Benzene (200)

0.26

± 0.01

0.15

± 0.02

0.14

± 0.01

Toluene (100)

0.28

± 0.03

0.18

± 0.02

0.16

± 0.01

0.23

± 0.01

0.14

± 0.01

0.15

± 0.02

Benzene (200)

+
Toluene (100)

a Values are given as mean

± S.E.

(n=5). Amounts of other amines or their metabolites were not

detected.
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